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Abstract
In blood flow in smaller blood vessels, red blood cells form a central core of flow and gives
rise to a phenomenon known as margination. Margination is defined as the movement of a
particle towards the periphery of blood vessels in blood flow. The margination of drug
carriers, in particular, is desirable for the treatment of diseases because particles that exhibit
marginating behavior are easier to diffuse into and/or target disease sites and deliver their
drug payload. Experimentally, almost all existing studies of particle margination use
particle adhesion as a mechanism for quantifying the margination propensity of particles.
However, particle adhesion does not necessarily translate to margination and is affected by
a number of other factors, limiting the conclusions that can be drawn from the results of
these studies. This research investigates the margination of particles under various
conditions via the use of direct particle tracking and without the limitations of an adhesion
mechanism. Particle size, flow rate and margination distance were first investigated,
finding that margination tends to increase with increasing particle size and with increasing
flow rate. Furthermore, it was observed that smaller particles appear to require less channel
length in the flow direction before significant margination was observed. Lastly,
experimental evidence of larger margination velocities in blood were found, supporting
modeling studies that suggest that particle-red blood cell interactions are largely
responsible for margination. An interesting observation during this study was that the
particle distribution after the channel constricted to its normal length from the inlet
reservoir seemed to affect the margination of particles. A follow-up study of the effects of
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constrictions on margination was begun, with applications to the treatment of
arteriolosclerosis. In this study, the percent occlusion, length and eccentricity of a
constriction and expansion region were all varied. Increasing percent occlusion and
constriction length were each found to increase margination. A decreasing eccentricity,
signifying a more gradual constriction entrance, was found to lead to decreasing
margination except for the case of a sudden constriction/expansion geometry which also
exhibited low margination. The presence of a constriction led to enhanced margination
with the presence of an expansion resulting in the opposite. In the final part of this work,
pulsatile flow was investigated. Margination in both steady and pulsatile flow was
compared and no significant difference was found. Further, the wait time between pulses
was varied and no difference in margination was observed. However, the variation of the
amplitude of the pulsatile flow did display increasing margination with increasing
amplitude, in line with the flow rate observations from the first experimental study.
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1 Background
1.1 Circulatory System
The circulatory system of the body is made up of arteries and veins. These blood
vessels have walls that are generally made up of endothelial cells and have diameters
ranging from 1.5 cm for the aorta of the heart down to approximately 8 µm for a small
capillary (Charm and Kurland 1974). The circulatory system is responsible for transporting
blood and, by extension, oxygen, to each cell that makes up the body.
1.2 Properties of Blood
Blood is a biological fluid and is made up of a number of components. First are the
erythrocytes, or red blood cells (RBCs). The volume fraction or percentage of RBCs in
blood is known as the hematocrit and can vary from about 36% to 53% in humans (Kratz ,
Ferraro et al. 2004, Zhao, Shaqfeh et al. 2012). RBCs are typically shaped as biconcave
discs approximately 8 µm in diameter and 2 µm in thickness and are also very elastic, or
“floppy” (Pries, Secomb et al. 1996, AlMomani, Udaykumar et al. 2008, Sun and Munn
2008, Kumar and Graham 2011). Next, approximately 1% of blood volume is made up of
leukocytes, or white blood cells (WBCs), which are spherical cells of approximately 8.5µm in diameter and defend the body against infection (Schmid-Schonbein, Sung et al.
1981, Pries, Secomb et al. 1996, Yang, Forouzan et al. 2011). Finally, platelets make up a
blood volume of approximately 0.7% and are responsible for blood clotting in the case of
an open wound (Tokarev, Butylin et al. 2011). Thrombocytes, or platelets, have a discoidal
shape; they are approximately 2-4 µm in diameter and 1 µm in thickness and are also much
stiffer than RBCs (AlMomani, Udaykumar et al. 2008, Zhao, Shaqfeh et al. 2012). All of
the components of blood are suspended in plasma, a liquid that makes up approximately
1

55% of total blood volume (Baele 2010). Blood plasma is mostly water but also contains
hormones, nutrients, the end-products of cellular metabolism, clotting factors,
immunoglobulins and proteins such as albumin (Baele 2010).
Because blood is a complex, multicomponent fluid, the modeling and analytical
prediction of its flow behavior is challenging as it has shear-thinning properties due to
being a cellular suspension. Its non-Newtonian nature combined with the various
suspended cells and their interactions makes blood a very difficult fluid to predict
accurately. Indeed, the presence of cells can have an effect on the flow behavior of blood
beyond it being non-Newtonian. In smaller blood vessels, typically with diameters less
than approximately 300 to 500 µm, RBCs have been found to move toward the center of
the vessel and to tend to push other particles towards the walls of the blood vessel (Pries,
Secomb et al. 1996, Lim, Ober et al. 2012, Carugo, Capretto et al. 2013). This phenomenon
is termed margination.
1.3 Margination
Margination is currently defined as the movement or migration of a particle or cell
in blood flow towards the periphery of the blood vessel. This movement towards the wall
of a blood vessel was first observed as a naturally occurring phenomenon but it was soon
discovered that other particles, including drug-carrying particles, are also capable of
marginating.
1.3.1 History
In physiology, margination refers to the migration of WBCs toward the
endothelium during blood flow and is relevant to the process of inflammation. Margination
and the subsequent adhesion of WBCs to the endothelium allows the WBCs to transmigrate
2

across the endothelial wall and enter an inflamed area of tissue. The margination of WBCs
was first observed in the blood vessels of tadpole tails by Dutrochet in 1824 (Dutrochet
1824). It was again observed by Gert Vejlens in 1938 and the margination of WBCs was
correlated with the aggregation of RBCs in vivo (Vejlens 1938). WBC margination is often
followed by: 1) their adhesion to blood vessel walls, 2) the movement of the WBCs into
the space between the endothelial cells, 3) the transport of WBCs through tissue, and 4)
the treatment of inflammation by the WBCs. The steps following the margination of WBCs
are fairly well understood, but the exact origin and detailed mechanisms that lead to
margination remain somewhat unclear (Langer and Chavakis 2009). While WBCs were
the first “particles” that were observed to display the propensity to marginate, other
particles, such as platelets and nanoparticles, have also been observed to exhibit
margination in blood flow (Charoenphol, Onyskiw et al. 2012, Lim, Ober et al. 2012,
Namdee, Thompson et al. 2013). One of the first mentions of particle margination is by
Segré and Silberberg in 1962 during their studies of rigid spheres suspended in a mixture
of glycerol, 1-3 butanediol, and water (Segré and Silberberg 1962). The authors observed
that polymethylmethacrylate (PMMA) spheres, with radii ranging from 0.32 mm to 1.71
mm, migrated away from the center of the tube and moved closer to the wall of the tube in
Poiseuille flow (Segré and Silberberg 1962).
1.3.2 Applications
The margination of particles in blood has applications in microfluidic devices for
the removal of pathogens and also for the separation of cells (Munn and Dupin 2008, Hou,
Bhagat et al. 2010, Jain and Munn 2011, Hou, Gan et al. 2012). Margination is especially
relevant to cancer diagnostics and therapy wherein it can bring sensing, imaging, and/or
3

therapeutic nanoparticles closer to capillary entrances, which are located near the periphery
of the larger blood vessels, thereby allowing these nanoparticles to enter the
microcirculation more readily (Gentile, Chiappini et al. 2008). Margination also allows
the particles to come close to the endothelium and, by attaching biorecognition molecules
such as antibodies to nanoparticles, the nanoparticles can then be used to sense the
increased amount of integrins and receptors of tumor endothelial cells (Godin, Serda et al.
2010).
In terms of therapeutics, margination enhances the diffusion of drug-carrying
nanoparticles into the tumor sites through the Enhanced Permeability and Retention (EPR)
effect that results from the characteristic leaky vasculature and lack of lymphatic vessels
near tumor (Decuzzi, Pasqualini et al. 2009). For some bioimaging applications, low or no
margination propensity may be desirable so that the nanoparticles will circulate in the blood
stream for an extended period of time (Godin, Serda et al. 2010). An understanding of the
fundamentals of margination is important to the engineering of particles for more effective
drug delivery (Carboni, Tschudi et al. 2014). It is, therefore, vital to understand the
mechanisms that are responsible for margination, including the physics of blood flow that
leads to it and also the effects that different particle properties, suspending media and flow
properties can have on the magnitude of margination in a system.
1.4 Mechanisms of Margination
While the reasons for the occurrence of margination are not completely understood,
it is thought that blood flow and the resultant forces and interactions that arise from the
unique properties of blood are responsible. As such, it is important to first understand the
physics of blood flow and the forces that can result from it. Brownian motion may play a
4

role in the margination phenomena as well and several studies have found that
heterogeneous particle collisions, or collisions between an elastic RBC and stiffer particles,
may be the major cause of margination.
1.4.1 Physics of Blood Flow
Blood flow in the body is generally considered as laminar flow, although the flow
can become turbulent under certain conditions, such as in the ascending aorta (Gulan, Luthi
et al. 2012). In laminar flow, a simple Newtonian fluid exhibits a parabolic velocity profile
and the flow is comprised of a multitude of fluid layers, oriented parallel to one another in
the flow direction, that travel smoothly without disruption alongside one another. Unlike
turbulent flow, wherein fluid naturally experiences irregular disruptions and, as a result,
lateral mixing, in laminar flow there is no occurrence of lateral mixing from fluid
convection. Laminar flow and turbulent flow are described by the dimensionless Reynolds
number, which is a ratio between the inertial and viscous forces acting on a flowing fluid.
The Reynolds number is given by:
𝑅𝑒 =

𝑖𝑛𝑒𝑟𝑡𝑖𝑎𝑙 𝑓𝑜𝑟𝑐𝑒𝑠
𝑣𝑖𝑠𝑐𝑜𝑢𝑠 𝑓𝑜𝑟𝑐𝑒𝑠

=

𝜌𝑢𝐿
µ

(1-1)

where ρ is the density of the fluid, 𝑢 is the velocity of the fluid, L is the characteristic length
(e.g., the diameter or width of a blood vessel or channel), and µ is the dynamic viscosity of
the fluid. Turbulent flow occurs at high Reynolds numbers while laminar flow takes place
at low Reynolds numbers. Given the small diameter of many blood vessels in the human
body, blood flow is usually classified as being laminar, although blood is a non-Newtonian
fluid due to the presence of RBCs and other blood constituents. A generalized Reynolds
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number for a power law fluid, applicable here, was defined by Metzner and Reed (Metzner
and Reed 1955) as well as Madlener, Frey and Ciezki (Madlener, Frey et al. 2009) as:

Re genPL 

D n u ( 2  n )
K ((3n  1) /(4n))n 8( n 1)

(1-2)

where n is the power law index of the fluid and K is the flow consistency index of the fluid.
Unlike most fluids, the fact that blood is a cellular suspension means that unique effects
can occur even at extremely low Reynolds numbers due to the interactions between the
cells.
1.4.2 Cell-Free Layer
It was first observed by Goldsmith et al. that RBCs formed an RBC-rich core region
in the center of the flow in the vessel, which resulted in the formation of a cell-free layer
(CFL) near the endothelium that was free of RBCs (Goldsmith and Spain 1984). The
authors also found that WBCs added into glass tubes containing blood that was free of
RBCs did not exhibit margination (Goldsmith and Spain 1984). The CFL is thin,
approximately 3 μm thick for blood flow in a 40 μm diameter vessel, but its thickness
varies with the vessel diameter and geometry (Fedosov, Caswell et al. 2010). The
geometric change near bifurcations, for example, changes the trajectory of RBCs and this
geometry has been demonstrated to change the thickness of the CFL as a result of the nonuniform flow pattern (Fedosov, Caswell et al. 2010). Furthermore, higher flow rates tend
to break up RBC aggregates, thereby expanding the RBC-rich core and subsequently
decreasing the thickness of the CFL (Fedosov, Caswell et al. 2010). The reason for this
RBC-rich core region can be partially explained by the existence of lift forces.
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An asymmetric pressure field may be developed beneath or above the blood cells
as a result of the lubricating flow between the wall and a blood cell, resulting in a “wall lift
force” that pushes WBCs and RBCs away from the wall during fluid flow (Abkarian,
Lartigue et al. 2002, Abkarian and Viallat 2005). This lift force can be calculated by:
𝐹𝑙 = µγ̇

𝑟3
ℎ

𝑓(1 − 𝑉)

(1-3)

where µ is the viscosity of the medium, γ̇ is the shear rate, r is the radius of the particle, h
is the particle’s distance from the wall and 𝑓(1 − 𝑉) is a dimensionless function
(Abkarian, Lartigue et al. 2002, Abkarian and Viallat 2005). 𝑉 is the reduced particle
volume and is given by:
𝑉=4

Ѵ

𝑆 3/2
𝜋( )
3 4𝜋

(1-4)

where Ѵ is the enclosed volume and S is the surface area of the particle (Abkarian, Lartigue
et al. 2002, Abkarian and Viallat 2005). Generally, WBCs are stiffer than RBCs and
maintain a roughly spherical shape even in high shear flow. The lift forces acting on WBCs
are weak compared those acting on RBCs, allowing WBCs to maintain their position in the
CFL and remain close to the endothelium (Schmid-Schönbein, Usami et al. 1980,
Mohandas and Chasis 1993, Ferri, Lombardini et al. 1994, Abkarian and Viallat 2005).
Conversely, the discoidal shape of RBCs, combined with their elasticity and membrane
fluidity, results in strong lift forces that push RBCs toward the center of the channel and
lead to the formation of a CFL close to the endothelium (Schmid-Schönbein, Usami et al.
1980, Abkarian and Viallat 2005). This movement, termed the “axial migration” or
focusing of RBCs, has been observed in multiple studies and is typically found in channel
diameters less than approximately 300 to 500 µm (Bayliss 1959, Goldsmith and Mason
7

1961, Pries, Secomb et al. 1996, Lim, Ober et al. 2012, Carugo, Capretto et al. 2013). The
formation of the CFL further leads to a decrease in the hydrodynamic resistance, which
allows the WBCs to marginate more easily and reach the vessel wall (Bishop, Popel et al.
2001, Fedosov, Fornleitner et al. 2012). The deformability of the RBCs is crucial to their
accumulation in the center of the vessel. In malaria patients, RBCs are significantly stiffer
and these infected RBCs have been shown to exhibit margination (Hou, Bhagat et al. 2010).
Lift forces are generally thought to be responsible for the formation of a RBC-rich core
region in the center of the blood vessels and for the margination of WBCs to the wall.
However, according to equation 1-3 , the actual lift forces acting on RBCs and WBCs also
strongly depend on the actual cell size to the third-power (Abkarian, Lartigue et al. 2002).
The authors of this paper noted that in reference (Abkarian and Viallat 2005) WBCs were
calculated to have a slightly larger lift force (46 pN – 230 pN) than the RBCs (31 pN – 155
pN) based on the blood cell sizes assumed.
1.4.3 Brownian Motion
The Péclet number is a dimensionless quantity that describes the mass transport by
taking the ratio of the convective transport by the fluid motion, and the diffusive transport
by the chemical potential difference, mainly due to a concentration gradient (Kirby 2010).
The Péclet number is given by (Kirby 2010):
𝑃𝑒 =

𝑐𝑜𝑛𝑣𝑒𝑐𝑡𝑖𝑣𝑒 𝑡𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑟𝑎𝑡𝑒
𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑒 𝑡𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑟𝑎𝑡𝑒

=

𝐿𝑢
𝐷𝑡𝑟𝑎𝑛𝑠

(1-5)

where L is the characteristic length, u is the average velocity of the fluid and Dtrans is the
translational diffusion coefficient (Kirby 2010). Higher Péclet numbers indicate a larger
hydrodynamic contribution to mixing whereas low Péclet numbers indicate a larger
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diffusional contribution. For a dilute suspension and a small Re number, the translational
diffusion coefficient of a spherical particle can be calculated using the Stokes-EinsteinSutherland equation (Kirby 2010):
𝑘 𝑇

𝐵
𝐷𝑡𝑟𝑎𝑛𝑠 = 6𝜋η𝑅

(1-6)

where 𝑘𝐵 is the Boltzmann constant, T is the temperature, µ is the viscosity of the
suspending medium and r is the radius of the spherical particle. According to equations 15 and 1-6, small particles have a higher diffusion coefficient and the corresponding Péclet
number is smaller. This implies that diffusive transport becomes more significant in the
case of nanoparticles. The end result is the random Brownian motion of nanoparticles,
wherein the particles fluctuate across streamlines (Einstein and Fürth 1956).
1.4.4 Heterogeneous Collisions
Particle dynamics simulations by Graham and co-workers revealed that collisions
between “stiff” and “floppy” particles in a suspension resulted in the eventual movement
of stiff particles towards the wall (Kumar and Graham 2011, Kumar, Henríquez Rivera et
al. 2014). Collisions in the near-wall region between stiff and floppy particles resulted in
a greater displacement of the stiff particles towards the wall, and margination did not occur
in cases where only one particle type was present (Kumar and Graham 2011, Kumar,
Henríquez Rivera et al. 2014). It follows that once a stiff particle reaches the near-wall
CFL, it tends to remain there (Kumar and Graham 2011, Kumar, Henríquez Rivera et al.
2014). This phenomenon in combination with the CFL, which arises from lift forces, is
thought to be responsible for the margination of particles in blood flow (Narsimhan, Zhao
et al. 2013). Further, the migration velocities and collision tendencies of particles were
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linked with margination behavior (Henríquez Rivera, Sinha et al. 2015). Despite the
discovered importance of these interactions, however, particle properties can also have a
very large impact on the margination propensity of particles, presumably by altering the
magnitude or frequency of particle-RBC interactions (Kumar and Graham 2011, Kumar
and Graham 2012, Carboni, Tschudi et al. 2014).
1.5 Effects of Particle Properties on Margination
Margination propensity is dependent on parameters such as the particle size, shape,
density, stiffness, and concentration and aggregation state of red blood cells. The following
is an overview of the experimentally observed effects of varying each of these properties
on the margination of smaller particles (<~5 µm diameter).
1.5.1 Particle Size
The size of a particle is an important parameter. Particles larger than 200 nm are at
risk of being filtered out of the blood or destroyed by the liver, spleen, and bone marrow,
whereas particles less than approximately 10 nm will leave the blood stream through the
kidney or via extravasation from a tumor (Liu, Tan et al. 2012). For margination to occur,
the particles need to escape the fluid-flow streamlines and move laterally as a result of
gravity, buoyancy, hydrodynamic forces, van der Waals forces, and/or Brownian motion
(Toy, Hayden et al. 2011). In the case of nanoparticles, gravitational forces are usually
neglected given the small size of the particles (Lee, Ferrari et al. 2009). However, as
particle size increases, gravitational forces become increasingly important. Gentile et al.
studied spherical particles with diameters of 50, 100, and 200, 500, 750 nm and 1, 6, and
10 μm (Gentile, Curcio et al. 2008). They found that gravity facilitated the margination of
the larger (> 500 nm) particles in the direction of the gravitational force (Gentile, Curcio
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et al. 2008). A modeling study by Lee et al. confirmed these results and found that for
smaller particles (< 500 nm), gravity has a negligible effect compared to Brownian motion
(Lee, Ferrari et al. 2009). Toy et al. measured the margination of spherical nanoparticles
ranging from 60 to 130 nm diameter in a bloodless solution via their adhesion to the walls
of a microfluidic channel (Toy, Hayden et al. 2011). They observed a faster margination
time for smaller particles and attributed it to their higher diffusivity, as explained in Section
3.2 (Toy, Hayden et al. 2011).
According to a modeling study by Decuzzi et al., gravitational forces dominate far
from the endothelium, whereas van der Waals forces dominate close to the endothelium
(Decuzzi, Lee et al. 2005). The van der Waals forces cause a “jump into contact” behavior
where the particle is suddenly attracted to the endothelium. The authors also found that the
competition between electrostatic, van der Waal, steric and buoyancy forces leads to a
critical radius where the margination time is the longest, as shown in (Decuzzi, Lee et al.
2005). Below and above this radius, the nanoparticles marginate more readily (Decuzzi,
Lee et al. 2005). The calculated critical radius varies from 50 to 250 nm, depending on a
number of factors, such as the particle density, blood ionic concentration, and endothelial
cell electrostatic properties (Decuzzi, Lee et al. 2005). It should, however, be noted that the
analytical model developed by Decuzzi et al. considered the interactions between
nanoparticles and endothelial cells only; no interactions between nanoparticles or between
blood cells and nanoparticles were included in the model (Decuzzi, Lee et al. 2005). Gentile
et al. found experimentally, for the discrete bead sizes that they used, that there were two
distinct margination mechanisms, based on the particle diameter (Gentile, Curcio et al.
2008). The 500 nm to 10 μm particles were found to be largely affected by gravity, whereas
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the 50 to 200 nm particles were found to be largely affected by collodial forces, such as
van der Waals forces (Gentile, Curcio et al. 2008). However, because particles of discrete
sizes were used, the exact critical diameter is unknown and the gravitational effect between
200 to 500 nm is unclear.
Charoenphol et al. examined the particle size effect experimentally using spheres
with a diameter ranging from 0.5 to 10 μm suspended in blood (Charoenphol, Huang et al.
2010). They observed that the margination propensity of particles increased with increasing
particle size, as shown in (Charoenphol, Huang et al. 2010). Namdee et al. observed that
micron-sized spheres (2 and 5 μm diameter) marginated much more effectively than
spherical nanoparticles (200 and 500 nm diameter) in a suspension of RBCs (Namdee,
Thompson et al. 2013). They further attributed the reduced margination of nanoparticles to
the trapping of nanoparticles within the spaces between the RBCs (Namdee, Thompson et
al. 2013). A similar observation was made by Lee et al. in a combined experimental and
modeling study (Lee, Choi et al. 2013). In the experimental portion, fluorescent
nanoparticles were tracked in the microvasculature of a mouse via intravital video
microscopy and 1 μm particles were found to exhibit margination whereas 200 nm particles
were found to distribute randomly in the blood vessel, with no apparent tendency to
marginate (Lee, Choi et al. 2013). In the modeling part of the study, the model showed that
nanoparticles (<100 nm) moved along with the RBCs in the core of flow whereas the larger
particles(0.5 to 1μm) exhibited margination (Lee, Choi et al. 2013).
D’apolito et al. studied particle size effects in a direct tracking study and found that
3 µm particles showed enhanced margination compared to 1 µm particles (D'Apolito,
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Tomaiuolo et al. 2015). However, it should be noted that a manual tracking procedure was
employed and a very limited number of particles was likely observed as a result of this.
1.5.2 Particle Shape
Many experiments use only spherical nanoparticles in their study of margination
(Segré and Silberberg 1962, Decuzzi, Lee et al. 2005, Gentile, Curcio et al. 2008,
Charoenphol, Huang et al. 2010, Lee, Choi et al. 2013, Namdee, Thompson et al. 2013).
For non-spherical particles, the physics is more complicated. The velocity gradient in fluid
flow results in a non-uniform distribution of forces along the axis of symmetry of the
particles, leading to particle rotation. Toy et al. studied the margination of

gold

nanospheres versus that of gold nanorods with a width-to-length ratio of 0.45 suspended in
water (Toy, Hayden et al. 2011). The gold nanorods were shown to exhibit a much higher
margination propensity when compared to the gold nanospheres (Toy, Hayden et al. 2011).
Likewise, Gentile et al. observed that disc-shaped and hemispherical nanoparticles
marginated more compared to spherical nanoparticles (Gentile, Chiappini et al. 2008).
However, this study focused on the sedimentation of particles and so the differently shaped
nanoparticles also had different densities (Gentile, Chiappini et al. 2008). Doshi et al.
studied how the shape and size of particles influence margination in a bifurcating
microfluidic device (Doshi, Prabhakarpandian et al. 2010). Particles investigated included
spheres of 1, 3 and 6 μm diameter, which were then stretched to form elliptical discs,
circular discs, and rod-like particles. Higher aspect ratio particles tended to exhibit greater
particle adhesion overall, with the difference becoming more pronounced with larger
particle size (Doshi, Prabhakarpandian et al. 2010). This could be attributed to the greater
contact surface area between the bovine serum albumin (BSA) antibody-conjugated
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particle and the BSA-coated wall, making the higher aspect ratio particles more likely to
bind and “stick” to the vessel walls. Lee et al. found that higher rotational inertia leads to
more pronounced lateral drifting and, thus, a larger margination propensity (Lee, Ferrari et
al. 2009).
For non-spherical particles, margination does not show a clear trend as a function
of shear rate. High shear rates can pull the nanoparticles off from the endothelium when
particle adhesion is used for the measurement of margination propensity, as previously
discussed (Section 3.2). Tan et al. simulated spheres with varying particle densities, rods
with an aspect ratio of three, and rods with an aspect ratio of five (Tan, Shah et al. 2013).
They found that, similar to the results obtained by Gentile et al. and Toy et al. (Gentile,
Chiappini et al. 2008, Toy, Hayden et al. 2011), the spheres and the rods exhibited
decreasing margination with increasing shear rates (Tan, Shah et al. 2013). They postulated
that the trend comes from the competition between the adhesion to the walls and drag forces
(Tan, Shah et al. 2013). At low shear rates, the adhesion forces are larger than the drag
forces, regardless of the particle orientation. At higher shear rates, these forces depend on
the orientation of the particle. If there is only a point contact, then the drag force is stronger
than the adhesion force whereas if a particle’s long axis is adhered to the endothelium, then
the adhesion force can overcome the drag force (Tan, Shah et al. 2013).
1.5.3 Particle Density
In an experimental study by Toy et al., 65 nm particles with different densities were
studied (Toy, Hayden et al. 2011). It was found that nanoparticles with a higher density
adhered less than those with a lower density (Toy, Hayden et al. 2011). Toy et al. explained
that the higher-density particles carried more momentum and, as a result, hydrodynamic
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forces dominated, whereas the low-density particles were dominated by diffusive motion,
allowing them to escape streamlines (Toy, Hayden et al. 2011). However, when the effects
of gravity are included, such as for larger particles, the effect reverses. In Gentile et al.’s
study, differently shaped particles with sizes of approximately 1 μm had drastically
different margination propensities (Gentile, Chiappini et al. 2008). The discoidal particles
were 20% heavier and the number of particles marginated was five times larger relative to
the spherical particles (Gentile, Chiappini et al. 2008). Likewise, the margination of
hemispherical particles that were 60% heavier was three times larger than that of the
spherical particles (Gentile, Chiappini et al. 2008). Both Toy et al. and Gentile et al. studied
particles in an aqueous medium with no blood cells. Toy et al. used sub-100 nm particles
whereas Gentile et al. used particles ranging in size from 1 – 3 μm and focused only on
their sedimentation to the bottom surface of the flow chamber – not their margination to
any wall. This may explain the discrepancy in results between the two studies.
1.5.4 Particle Stiffness
There are two different views on the effect of RBC stiffness on WBC margination.
Freund modeled the interactions between RBCs and WBCs and the subsequent effect on
WBC margination (Freund 2007). He increased the stiffness of RBCs by a factor of 10, but
the WBCs exhibited only slightly decreased margination (Freund 2007). The author
concluded that the margination of WBCs does not have a strong dependence on the
deformability of RBCs and is likely more dependent on the mismatched size or shape of
RBCs and WBCs (Freund 2007). Kumar and Graham mathematically modeled a system
comprised of a dilute suspension of neo-Hookean capsules between infinite parallel walls,
subjected to simple shear flow (Kumar and Graham 2011). Contradicting the results of
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Freund, they found that stiff particles, such as WBCs, tend to marginate whereas more
elastic (“floppy”) particles, such as RBCs, undergo the opposite phenomenon and
accumulate at or near the center of the channel (Kumar and Graham 2011). The study first
modeled systems comprised entirely of stiff particles or entirely of elastic particles, and no
margination was observed (Kumar and Graham 2011). However, upon modeling a system
comprised of both types of particles, the stiffer particles were observed to migrate nearer
to the wall of the channel and the elastic particles were observed to remain in the center of
the channel (Kumar and Graham 2011). Kumar and Graham proposed that heterogenous
collisions — collisions between stiff and elastic particles — were responsible for the
margination of the stiffer particles (Kumar and Graham 2011). This accurately describes
the phenomenon of RBC aggregation in the center of a blood vessel and WBC margination
to the walls of the blood vessels. Interestingly, Kumar and Graham also found that the
heterogenous collisions had a much larger displacement effect on the stiffer particles
towards the wall than on the elastic particles (Kumar and Graham 2011, Kumar and
Graham 2012).
1.5.5 Shear Rate
Shear rate affects the shape of the WBCs or particles, which will in turn modify the
adhesion and lift forces acting on those particles. A number of studies showed that WBC
margination increases significantly as a function of decreasing shear rate (Goldsmith and
Spain 1984, Nobis, Pries et al. 1985, Firrell and Lipowsky 1989, Abbitt and Nash 2001,
Freund 2007). Similar trends have been reported for particles. Toy et al. coated the channel
walls with fibronectin to capture nanoparticles that marginated and, therefore, came close
to the wall (Toy, Hayden et al. 2011). They reported that increasing shear rate decreased
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the margination and further attribued this to the detachment of nanoparticles at high shear
rates (Toy, Hayden et al. 2011). Namdee et al. came to a similar conclusion when using 2
and 5 μm spherical particles in an adhesion-based assay (Namdee, Thompson et al. 2013).
Charoenphol et al. seeded endothelial cells onto glass and inserted the glass substrate into
a flow chamber (Charoenphol, Huang et al. 2010). Particles were bound with ligands,
which in turn bound to receptors on the endothelial cells. They observed that particle
binding initially increases as a function of shear rate because, for the same particle
concentration, the number of particles passing through the channel increases and thus the
chance for particles to bind onto the wall increases (Charoenphol, Huang et al. 2010).
However, as the shear rate exceeded a certain critical value, the number of particles bound
to the wall decreased as a function of shear rate (Charoenphol, Huang et al. 2010). Gentile
et al. found that the number of particles that marginated via sedimentation has a empirical
power-law relationship with the shear rate (Gentile, Chiappini et al. 2008). The exponent
varied for differently shaped particles: 𝛾̇ -0.63 for spherical particles, 𝛾̇ -0.85 for discoidal
particles, and 𝛾̇ -1 for quasihemispherical particles, respectively (Gentile, Chiappini et al.
2008).
1.5.6 Hematocrit and RBC Aggregation
Margination is affected by the interactions between particles and RBCs. Tan et al.
modeled particle margination with and without RBCs and showed that margination was
almost doubled in the case with RBCs (Tan, Thomas et al. 2012). The enhanced
margination in the presence of RBCs was more pronounced at higher shear rates, where
the RBCs tumbled faster. A number of studies investigated the effect of hematocrit — the
volume percentage of RBCs in blood — on WBC margination. Fedosov, Fornleitner and
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Gompper found in their modeling study that the margination of WBCs was highest at
hematocrits of 25% and 35% (Fedosov, Fornleitner et al. 2012). For a hematocrit of 55%,
the authors found that RBCs caused a “lift-off” mechanism, wherein the RBCs entered the
gap between the WBC and the wall and lifted the WBCs off the wall (Fedosov, Fornleitner
et al. 2012). It should be noted that this “lift-off” mechanism is completely different from
the lift force. No explanation was, however, given for why margination of WBCs at 45%
hematocrit was lower than that of WBCs at hematocrits of 25% and 35%.
In studies where particle adhesion was used to quantify margination, there is a
disagreement over whether hematocrit affects particle margination. Charoenphol et al.
reported changes in hematocrit did not affect the margination of spherical particles ranging
from 100 nm to 10 μm (Charoenphol, Huang et al. 2010). However, another study by
Namdee et al. reported that increasing the hematocrit from 30% to 50% increased the
adhesion of nanoparticles, but reduced the adhesion of micron-sized particles (Namdee,
Thompson et al. 2013). The decrease in adhesion for the micron-sized particles could be
explained by the comparable size of the CFL to the size of the particles, causing RBCs to
collide with the particles and knock the particles off of the wall (Namdee, Thompson et al.
2013). The discrepancy between the Charoenphol and Namdee studies could be a result of
the difference in the size of the flow chamber used in each study and thus the thickness of
the CFL.
One direct-tracking study exists that explores the effects of hematocrit variation.
Fitzgibbon et al. investigated margination in a 300 µm width and 30 µm height channel
with varying hematocrit from 10 to 30% via the use of direct, manual tracking. They found
an increase in rate of particle margination when they increased the hematocrit from 10%
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to a value to 20% but were unable to evaluate the effects of 30% due to clotting issues and
a potentially poor blood sample. The 30% hematocrit experiment was, unfortunately, not
repeated after the initial issues arose and so no results could be gleaned from the
experimental portion of the study despite the simulation portion indicating that 30%
hematocrit should show the most rapid margination.
Lastly, there are also conflicting views on whether the aggregation of RBCs affects
margination. Jain and Munn perfused a device with dextran solutions and a plasma-free
culture medium, respectively (Jain and Munn 2009). The highest margination propensity
of WBCs was observed in the presence of dextran, which induced RBC aggregation at a
similar level to that of RBCs in plasma (Jain and Munn 2009). Likewise, Pearson and
Lipowsky demonstrated in their in-vivo experiments that the addition of dextran 500
(Dx500), a high molecular weight dextran known to increase the aggregation of RBCs,
increased margination fourfold whereas the addition of dextran 40 (Dx40), a known
disaggregating agent, decreased the margination of WBCs by half in the post-capillary
venules of rats (Pearson and Lipowsky 2000). Furthermore, Fedosov, Fornleitner and
Gompper found that the aggregation between RBCs at higher hematrocrits led to a tighter
RBC packing and supressed the “lift-off” mechanism (Fedosov, Fornleitner et al. 2012).
However, Freund found in his modeling study that WBCs marginated without RBC
aggregation, suggesting that WBC margination does not depend on RBC aggregation
(Freund 2007).
1.6 Research Objectives
The overarching purpose of this research was to experimentally investigate the effects
of various parameters on the margination ratio in order to elucidate the mechanisms behind
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it and to find the ideal conditions or particle properties for margination to take place, for
drug delivery applications. The major research objectives and the associated specific aims
were as follows:
(1) Measure margination of model polystyrene particles in varying circumstances via the
use of an in-house developed, automated direct particle tracking methodology (Chapter
2), with the specific aims:
•

Develop an in-vitro system that mimics the conditions in an arteriole in the
human body with the help of microfluidics and utilizing either a syringe pump
or a pressure-driven pumping system to generate flow

•

Aid in the development of MATLAB™ particle tracking code for the direct
tracking of moving particles

•

Compare the effects of suspending media and if any margination is present in
water vs blood

•

Using direct tracking, find the migration velocities of particles in water and
blood and compare the extent of y-movement between the fluids

•

Study differing discrete particle sizes and discern the relationship between
particle size and margination propensity

•

Investigate the effects of margination distance on the extent of particle
margination

•

Examine different flow rates and the impacts of varying flow rate on particle
margination
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(2) Explore the effects of constricted channels on the margination of particles in blood flow
(Chapter 3), with the specific aims:
•

Design and fabricate microfluidic devices with controlled geometrical
variations

•

Check water as a suspending medium and if any basic geometric effects are
observed in a simple fluid without the presence of RBC-particle interactions

•

Investigate the effects of varying channel occlusion percentage, constriction
length and eccentricity of the constriction on particle margination

•

Quantify particle margination just before and just after a constriction and just
before and just after an expansion to find the individual contributions to
margination of each geometric change

(3) Examine the effects of pulsatile flow on particle margination in small blood vessels
(Chapter 4), with the specific aims:
•

Develop scripts for the pump and flow controller that replicate a physiologically
relevant pulsatile flow

•

Fit data to a sine curve to ensure a good fit, which indicates that the pump is
capable of reproducing physiological pulsatile flow

•

Compare margination in steady vs pulsatile flow and explore the possible
mechanics if there are differences

•

Vary the wait time between pulses and the amplitude of each pulse and
investigate the effects of variations in each quality of the pulsatile flow
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2 Direct Tracking of Particles and Quantification of Margination in Blood Flow
2.1 Introduction
The current understanding of margination is that two driving forces contribute to it,
namely, wall-induced lift forces and heterogeneous collisions between red blood cells
(RBCs), WBCs, and particles. As a brief summary, lift forces arise from an asymmetric
pressure field developed as the particle deforms near the wall, which consequently pushes
cells or particles away from the wall (Abkarian, Lartigue et al. 2002, Abkarian and Viallat
2005). The magnitude of the lift force depends on the deformability of the cells or particles.
RBCs are less stiff than WBCs and, as a result, the lift forces experienced by RBCs are
larger, leading to the formation of a layer free of RBCs, known as the cell-free layer (CFL)
as shown in Figure 2-1(a) (Goldsmith and Spain 1984, Lim, Ober et al. 2012, Narsimhan,
Zhao et al. 2013). Further, particle dynamics simulations by Graham and co-workers
revealed that collisions between “stiff” and “floppy” particles in a suspension resulted in
the eventual movement of stiff particles towards the wall (Kumar and Graham 2011,
Kumar, Henríquez Rivera et al. 2014). Collisions in the near-wall region between stiff and
floppy particles resulted in a greater displacement of the stiff particles towards the wall,
and margination did not occur in cases where only one particle type was present (Kumar
and Graham 2011, Kumar, Henríquez Rivera et al. 2014). It follows that once a stiff particle
reaches the near-wall CFL, it tends to remain there (Kumar and Graham 2011, Kumar,
Henríquez Rivera et al. 2014). This phenomenon in combination with the CFL, which
arises from lift forces, is thought to be responsible for the margination of particles in blood
flow (Narsimhan, Zhao et al. 2013). Further, the migration velocities and collision
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tendencies of particles were linked with margination behavior (Henríquez Rivera, Sinha et
al. 2015).

Figure 2-1: (a) Blood flow showing the formation of CFL within a microchannel. (b) Plane
of focus for particle tracking with labeled imaging positions. (c) Schematic diagram of the
microfluidic channel used in this study with the plane of focus for particle tracking.
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A number of experimental (Decuzzi, Gentile et al. 2007, Gentile, Chiappini et al.
2008, Gentile, Curcio et al. 2008, Charoenphol, Huang et al. 2010, Doshi,
Prabhakarpandian et al. 2010, Toy, Hayden et al. 2011, Lee, Choi et al. 2013, Namdee,
Thompson et al. 2013, D'Apolito, Tomaiuolo et al. 2015) and theoretical (Decuzzi, Lee et
al. 2005, Lee, Ferrari et al. 2009, Müller, Fedosov et al. 2014, Müller, Fedosov et al. 2015)
studies have explored the effect of varying particle size on the margination propensity of
particles. Several studies suggested that larger particles marginate much more readily than
smaller particles and that there exists an optimal particle size for margination (Decuzzi,
Lee et al. 2005, Gentile, Curcio et al. 2008, Lee, Ferrari et al. 2009, Charoenphol, Huang
et al. 2010, Lee, Choi et al. 2013, Namdee, Thompson et al. 2013, Müller, Fedosov et al.
2015). There is, however, no consensus as to the exact particle size that results in optimal
margination. In terms of the effect of flow rate, Charoenphol et al. (Charoenphol, Huang
et al. 2010) reported that margination increased with increasing flow rate experimentally.
However, for a given particle concentration and duration, a larger total number of particles
would perfuse through the device at higher flow rates and this may explain the trend
observed. Interestingly, a later independent experimental study by Namdee et al. (Namdee,
Thompson et al. 2013) suggested that margination decreased with increasing flow rate,
contradicting the study by Charoenphol et al. (Charoenphol, Huang et al. 2010). Namdee
et al. attributed this to their measurement method, which involves perfusing a suspension
of fluorescent particles through a microfluidic channel, followed by buffer solution
flushing and measuring the fluorescence intensity emitted by particles that remained
adhered to the wall (Namdee, Thompson et al. 2013). Particles may have detached from
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the wall at higher flow rates due to increasing hydrodynamic drag and/or collision with red
blood cells (Namdee, Thompson et al. 2013).
Many studies in addition to the Namdee study use particle adhesion as a method of
measurement for the magnitude of margination. These studies conjugated particles with a
ligand and coated channels with a receptor or chose to model such a system in order to
measure the margination of various particles (Decuzzi, Gentile et al. 2007, Gentile,
Chiappini et al. 2008, Gentile, Curcio et al. 2008, Decuzzi, Pasqualini et al. 2009,
Charoenphol, Huang et al. 2010, Toy, Hayden et al. 2011, Tan, Thomas et al. 2012,
Namdee, Thompson et al. 2013, Tan, Shah et al. 2013). The conjugated particles became
bound to the walls of the channels upon coming into contact via margination. In this way,
margination was measurable based on the number of particles adhered to the walls. Particle
adhesion and margination are closely related. However, particle adhesion is also affected
by other factors such as hydrodynamic forces, the number of ligands and receptors, the
contact density, the characteristic length of the bond between the ligand and the receptor,
the temperature of the medium, and particle deformability (Decuzzi, Gentile et al. 2007,
Toy, Hayden et al. 2011).
Intuitively, the contact area of a spherical particle with the adhesion layer is
proportional to the particle radius, R, and the thickness of the adhesion layer. However, the
drag force experienced by the larger particle also increases. For a spherical particle, the
drag force is given as:
1

2
𝐹𝐷 = 2 𝜋𝜌𝑢𝑝𝑓
𝐶𝑑 𝑟 2
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(2-1)

where 𝑢𝑝𝑓 is the velocity of the spherical particle relative to the fluid, r is the particle
radius, ρ is the density of the fluid and Cd is the drag coefficient. The value of Cd depends
on the flow regimes. For small Reynolds numbers (calculated using the particle diameter
as the characteristic length), the flow is in the Stokes regime wherein Cd scales with r-1.
As a result, the ratio of the adhesion to the drag forces would be independent of the size of
the particle (𝐹𝐴 ⁄𝐹𝐷 ∝ 𝑟⁄𝑟). For large Reynolds numbers, the flow is considered to be in
the Newtonian regime, where Cd is a constant. Consequently, the ratio of the adhesion to
the drag forces would scale with r-1, implying that larger particles will detach from the
adhesion layer eventually due to larger hydrodynamic drag. Such a simple scaling
argument does not consider the collision between the RBCs and the adhered particles,
which may also lead to the dislodgement of particles from the adhered surface. For nonspherical particles, adhesion also depends on the particle orientation, which determines the
contact area between the particle and the endothelium and, therefore, the magnitude of the
adhesive force.
All existing experimental studies, with only two exceptions (D'Apolito, Tomaiuolo et
al. 2015, Fitzgibbon, Spann et al. 2015), assessed margination propensity based on the
number density, or more precisely the fluorescence intensity, of fluorescent particles
adhered to the channel wall after passing a particle suspension and subsequently a buffer
solution through the channel (Decuzzi, Gentile et al. 2007, Gentile, Chiappini et al. 2008,
Gentile, Curcio et al. 2008, Charoenphol, Huang et al. 2010, Doshi, Prabhakarpandian et
al. 2010, Toy, Hayden et al. 2011, Tan, Thomas et al. 2012, Namdee, Thompson et al.
2013, Tan, Shah et al. 2013). In this study, margination propensity is quantified based on
the direct tracking of individual particles. Direct tracking is less susceptible to the
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aforementioned factors involved in using adhesion as a method of margination
measurement, which could complicate the interpretation of experimental results.
Recently, direct tracking of particles has gained momentum as a result of the
limitations of the adhesion mechanism for the measurement of margination (D'Apolito,
Tomaiuolo et al. 2015, Fitzgibbon, Spann et al. 2015). In this method of margination
measurement, a section of a channel is imaged and all particles are tracked. Particle
velocities can be used to normalize the results and all particles in the CFL can be tracked
and recorded as marginating particles. These direct tracking studies paint a better picture
of the margination of particles in blood flow and suffer from none of the drawbacks of
adhesion studies in terms of result reliability. A direct tracking study by D’Apolito et al.
that was recently published focuses on different shapes of particles (D'Apolito, Tomaiuolo
et al. 2015). In this study, however, two spherical particle sizes were used and it was found
that the larger (3 μm) particles exhibited better margination when compared to the smaller
(1 μm) particles. However, since this study focused on particle shape as opposed to size,
these results are not conclusive and obviously do not cover smaller particle sizes that are
of interest. Smaller particle size is advantageous for diffusive drug delivery, specifically to
cancerous tumors due to the enhanced endothelial cell spacing in the walls of blood vessels
near a tumor site, and should not be ignored. This is especially true since prior adhesion
study results may not be reliable for particle size. Furthermore, this study manually tracked
particles and, as such, only analyzed a limited number of particles. This small sample size
could, in turn, lead to large errors in results.
Instead of manually tracking a limited number of particles, in this study a numerical
code was developed to track thousands of particles to ensure that the experimental results
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reported herein are statistically significant. Individual particles were experimentally
tracked to calculate velocities both in the flow direction and in the margination direction.
Mean square displacement data were further used to estimate the effective particle
diffusivities in water and blood, respectively. Third, the degrees of margination at different
travel distances from the inlet were assessed experimentally and analyzed for the first time.
2.2 Methodology
Defibrinated bovine blood (Lampire Biological Laboratories, Inc., Pipersville, PA)
was washed and adjusted to 35% hematocrit. This hematocrit was chosen because, for
channel diameters under 300 µm, the ratio of the hematocrit in the channel to that in the
feed reservoir decreases with decreasing channel width (Fåhraeus 1929, Barbee and
Cokelet 1971). As such, it is expected that a feed hematocrit of 35% will result in an
effective channel hematocrit of approximately 85% of the inlet hematocrit for a 100 µm
width channel (Barbee and Cokelet 1971), which works out to a hematocrit of 30%.
The bovine blood was washed to reduce particle adhesion to the channel walls and
substrate surface during experiments. The bovine blood was first centrifuged at 500x g and
the plasma was then decanted. Phosphate-buffered saline (Thermo Fisher Scientific Inc.,
Waltham, MA) was added to the blood to adjust it to a physiologically relevant 35%
hematocrit (Barbee and Cokelet 1971, Brizel, Klitzman et al. 1993). This process was
repeated twice more to ensure a thorough washing. While this process may have removed
bovine serum albumin and other proteins that are naturally present in blood plasma, it
served to minimize particle adhesion in the channel. In unwashed blood, this particle
adhesion to the bottom of the channel was found to make particle tracking difficult or
impossible. The degree of adhesion in unwashed blood could be a result of plasma proteins
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in blood, which have been known to cause dispersed RBCs to adhere to each other and may
have caused particles in this study to adhere to the channel sides or to the glass substrate
(Pries, Secomb et al. 1996). The difference between unwashed and washed blood is shown
in Figure 2-2. Furthermore, the washing of bovine blood and its resuspension in phosphatebuffered saline resulted in bovine RBCs that have similar elasticities to those of human
RBCs (Amin and Sirs 1985).

Figure 2-2: Fluorescent particle adhesion in unwashed vs washed blood
Spherical, fluorescent polystyrene particles (0.53, 0.84 and 2.11 μm diameter) were
used as model particles in the experimental system (Spherotech Inc., Lake Forest, IL).
These particle sizes were chosen because the endothelial cell spacing of leaky vasculature
near tumor sites typically varies from 0.2 µm to 2 µm (MacEwan, Callahan et al. 2010).
2.11 µm was chosen as the largest particle size. A smaller particle size (0.25 μm) was tested
initially, but accurate tracking of particle positions at the mid-plane was impossible due to
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limited fluorescence signal and the obstruction of red blood cells. As such, 0.53-µm
particles were chosen as the smallest particle size in this study. The original number
concentrations of particles were 1.22 x 1011, 3.07 x 1010 and 1.94 x 109 particles per mL
for the 0.53-, 0.84- and 2.11-μm particles, respectively. Polydimethylsiloxane (PDMS) prepolymer and curing agent were used for the fabrication of microfluidic devices (Silgard
184 Silicone Elastomer Kit, Krayden Inc., Denver, CO).
2.2.1 Microfluidic Device Fabrication
A conventional soft lithography technique using SU-8 photoresist (Thermo Fisher
Scientific Inc., Waltham, MA) was used to fabricate a silicon master. Briefly, SU-8 2025
photoresist (MicroChem Corp, Newton, MA) was spin-coated onto a 3” silicon wafer
(NOVA Electronic Materials, LLC., Flower Mound, TX), exposed to UV light through a
transparency photomask (Advanced Reproductions Corporation, North Andover, MA),
which was designed using AutoCAD software, and submerged in developer solution
(MicroChem Corp, Newton, MA). Upon drying, microfluidic devices were fabricated from
the silicon master using PDMS (Silgard 184 Silicone Elastomer Kit, Krayden Inc., Denver,
CO). Elastomer base and curing agent were mixed in a 10:1 ratio and degassed for 10
minutes. Next, the PDMS was poured over the master and degassed for an additional 10
minutes. The master was placed in an oven and the PDMS was allowed to cure for 2 hours
at 60 °C. The device was cut out with a scalpel and an inlet and outlet were created using
a 2-mm biopsy punch (Miltex Inc., York, PA) and punching vertically through the PDMS,
into the 2-mm landing pad area of the device (Figure 2-1(b)). Lastly, the PDMS device was
plasma bonded (Basic Plasma Cleaner PDC-32G, Harrick Plasma, Ithaca, NY) to a glass
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coverslip slide (#1.5, Thermo Fisher Scientific Inc., Waltham, MA) to form a completed
microfluidic device.
Of note during the step were several modifications to the general plasma-bonding
procedure. Instead of cleaning the PDMS device with isopropyl alcohol, tape was used and
dabbed onto the device repeatedly. This was found to effectively remove dust particles and
yield a far cleaner device than isopropyl alcohol and a fiber wipe. Additionally, using tape
removed the need for a drying step which removed a source of dust and other contamination
on the device. The next modification was that the device was plasma bound for
approximately 2 minutes instead of the recommended 45 seconds. This seemed to yield a
stronger, more consistent bond to the glass coverslip. Finally, there existed a requirement
to plasma bond and then put fluid into the device within 15 minutes in order to preserve
hydrophilicity. However, due to the nature of the experiments in this study, not only was
this impractical but it was also almost impossible to begin an experiment 15 minutes after
bonding a device. It was, however, found that both water and blood could be successfully
flowed through even a microfluidic device that had been plasma bound days or even weeks
beforehand. Furthermore, interestingly, the bond in older devices was much more effective
than in freshly-bound devices. To expand, many freshly bound devices had a corner or side
that could be partially peeled away immediately after plasma bonding, sometimes peeling
to the channel itself and rendering the device useless. Initially, this was considered a poor
bond. However, it was found that this occurs fairly frequently and that if a device is allowed
to rest for a while then the bond becomes extremely strong and the device can no longer be
peeled from the cover slip substrate (it is thought ~1 hour minimum, though a day or more
is best).
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With the previous additional findings related to effective plasma bonding, plasma
bonding very rarely failed and so these techniques were employed for every device once
they were discovered.
2.2.2 Experimental Apparatus
Spherical, fluorescent polystyrene particles (0.53, 0.84 and 2.11 μm diameter,
Spherotech, Inc., Lake Forest, IL) were diluted in the washed bovine blood and in water
such that the final number concentration was calculated to be 4.073 x 106 particles per mL.
A pressure-driven pump system with flow controller (Fluigent Inc., Villejuif, France) was
used to pump each of the solutions through the microfluidic device. The pressure-driven
pump system was chosen because it provides for superior flow rate control compared to
the syringe pump that was initially used in this study, as shown in Figure 2-3. This figure
shows individual particle velocities over the course of a typical experiment. As can be seen,
there are large fluctuations in the flow patterns of the syringe pump, with some vaguely
pulsatile tendencies being visible, whereas the pressure-driven pump shows a remarkably
constant flow. While syringe pumps are useful for larger volumetric flow rates, the very
tiny flow rate used in this study was an issue because the screw of the syringe pump could
only turn so slowly and ended up yielding a somewhat pulsatile but chaotic flow.
Fluid was pumped using the pressure-driven pump through the microfluidic device
at a physiologically relevant average velocity of 1 mm/s (Pries, Secomb et al. 1995,
Kubota, Tamura et al. 1996, Cai, Fan et al. 2012). This velocity corresponds to a volumetric
flow rate of 0.24 µL/min, an apparent shear rate of 61 s-1 and a wall shear rate of 67 s-1 for
the channel dimensions. Apparent wall shear rates depend on the volumetric flow rates as
well as the channel dimensions, but do not account for the non-Newtonian nature of blood
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or the formation of the CFL. For a rectangular channel with a width W and a height H, the
apparent shear rate is calculated as:

 6Q  H 
a  
1  f
2 
 WH  W 

H 
* 
W 

(2-2a)

where H is the channel height, W is the channel width, Q is the volumetric flow rate and f*
is a geometric constant based on the ratio of H and W (Son 2007). The wall shear rate is
calculated as:

 2  b * a * 1 

 w  a  

 3  f * f * n 

(2-2b)

Where n is the power law index of the fluid and a* and b* are also geometric constants
based on the ratio of H and W (Son 2007).
A number of 60,000-frame (~7.5 minutes) time-lapse videos of the flowing
suspensions were acquired at the middle plane of the microfluidic device, as shown in
Figure 2-1(c), using a dry objective lens (40x) with a high-speed camera (Andor iXon Ultra
897 iX0897 EMCCD, 130 frames/s, Andor Technology Ltd., Belfast, UK) and an inverted
fluorescence microscope (Nikon Eclipse Ti-E, Nikon Instruments Inc., Melville, NY) with
an Epifluorescence source (Intensilight C-HGFIE, Nikon Instruments Inc., Melville, NY).
After each time-lapse video was collected, the reservoir of blood was gently shaken to keep
the solution well mixed and the device was perfused at a high flow rate (~ 8 μL/min) for
approximately 2 minutes. After every four time-lapses, the entire system was flushed for
10 minutes before taking the next time lapse.
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Figure 2-3: Individual particle x-velocities vs. the first frame number that the particle
was tracked. 2.11-µm particles in water at a flow rate of 0.24 µL/minute, achieved using
(a) a syringe pump and (b) a pressure-driven pump. Frame rate: 130 frames per second.
2.2.3 Image Analysis and Particle Tracking
The collected time-lapse videos were analyzed using MATLAB® code developed
in-house. The particle tracking procedure consists of three major steps: (1) Background
Correction: each time lapse video was split into 60,000 separate images and a background
correction was performed to remove any bright pixels associated with particles adhered to
the bottom of the channel (2) Particle Identification and Tracking: image-by-image, the
position and size of all particles were calculated using a gradient-based method. The
calculated particle size was used to eliminate out-of-focus particles based on their apparent
larger size and the positions of all remaining particles were tracked as a function of time to
calculate their displacements and velocities (3) Post-Processing: the results were cleaned
of particles that were low-quality (i.e. only tracked for a few frames) or otherwise
questionable and the cleaned, final results of the tracking were saved.
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2.2.3.1 Background Correction
Despite the blood washing procedure, some particles adhered to the channel wall
when suspended in blood, obscuring the tracking of moving particles through the channel.
This was found to be especially significant for the case of the 2.11-µm particles, which are
prone to sedimentation. For this reason, a background correction method was developed to
remove the non-moving, fluorescent-light-emitting adhered particles and allowing the
moving particles to be clearly and precisely tracked, without the interference of background
noise from the adhered particles. However, since the number of adhered particles tended
to change over time, the background noise from adhered particles constantly changed in
both location and magnitude. To correct for this, a dynamic background correction method
was applied to all frames. This correction method involves removing the dynamically
computed background from each frame. For each frame, the computed background consists
of the average of the n previous and n subsequent frames. For these experiments, n was
arbitrarily set to 5 frames, which was enough to remove most noise from the background.
Figure 2-4 shows both a raw (a) and background-corrected (b) image, for reference.
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Figure 2-4: Fluorescent images of the microfluidic channel containing 2.11-µm particles
suspended in blood: (a) before background correction, featuring adhered particles that are
considered to be out-of-focus. The blue arrow points at an example out-of-focus particle
and (b) after background correction, where the moving particles have become clearly
visible. Moving particles are circled in red.
2.2.3.2 Particle Identification and Tracking
For all frames, a binary image was first generated based on the gradient of
brightness in the grayscale, background-corrected images. The contours of all particles
were detected based on a combination of the particle brightness and brightness gradient.
These closed contours were then filled, resulting in a binary image where the background
is black and the detected particles are white. For each individual particle detected on each
frame, its cross-sectional area and center of brightness were computed from the binary
image. Despite the shortest possible exposure time for the camera being used, many of the
tracked particles that are in-focus appear elongated in the collected time lapse videos as a
result of their high velocity. To ensure accuracy of particle positions as a result of this
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problem of motion blur, the particle position was calculated by taking the center of mass
of the particle based on the brightness (regardless of the apparent particle shape, elongated
or not), which corresponds to the particle position at half of the exposure time if a constant
particle velocity is assumed. This methodology ensures that the results were accurate and
consistent.
Some out-of-focus particles were tracked, but they appeared larger on the binary
image because of the “halo” generated around them. It is therefore easy to remove them
from the results, using a simple threshold on the value of the previously computed crosssectional area. Out-of-focus particles can be seen in Figure 2-4(a), adhered to the sides or
bottom of the channel. A particle adhered to the wall is pointed at with a blue arrow.
The result file from the particle detection constitutes a table containing time (t), xand y-position and cross-sectional area for all detected particles. The data required further
treatment. The result table contains a cloud of points in the (t, x, y, particle size) space,
where all particles are unrelated, except for being in order of appearance in the raw video
file. This section briefly describes how the particles were finally grouped together to
generate the time evolution of all tracked positions.
The sorting procedure is divided into three main steps: (1) detection and creation
of a new active particle, (2) updating of an active particle and (3) the deactivation of a
particle.
1. Detection and creation of an “active” particle: Particles that are detected but have
not been previously identified as an active particle are identified as new “active
particles”. These active particles are assigned a unique identifying number and
subsequently tracked.
37

2. Tracking an active particle: The trajectory of a particle, say, Particle A, is tracked
by defining a bin around this particle. A particle that appears at a later frame within
this bin will be treated as the same Particle A at its new position. If there is more than
one particle, the particle with the closest position to the predicted position (based on
previous displacement) will be treated as Particle A, and the corresponding
displacement will be recorded.
3. Deactivation of a particle: A particle is “deactivated” if it has not been updated for a
given number of time steps. This allows the tracking code to lose track of a single
particle for a few frames as long as that particle is found and tracked again in
subsequent frames. This deactivation procedure is included because particles may
become obscured by the blood cells or adhered particles.
The tracking of a particle from its first frame to its last frame in the imaging window can
be seen in Figure 2-5 (Particle #60).

Figure 2-5: Sample images showing the successful tracking of particles from the first to
the last frame for particle #60.
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2.2.3.3 Post-Processing
Occasionally, the identification numbers of two particles may be switched if they
are in close proximity or if they temporarily enter a region where the pixel brightness is
over-saturated. Particle switching is associated with a sudden change in velocity, and all
data points after that frame are removed. This procedure does not decrease the number of
tracked particles; it only reduces the number of tracked points for a given particle. Each
tracked particle’s identification number, size, and position at a given time were stored in
individual data cells. The minimum, maximum, and average y-position as well as the
average x- and y-velocity for each particle can be easily accessed and calculations based
on these values can be made whenever necessary.
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Figure 2-6: (a and b) Particle count per segment as a function of the normalized y-position
for 2.11-mm particles suspended in (a) water and (b) blood. Volumetric flow rate: 0.24
mL/min; apparent wall shear rate: 61 s-1. (c and d) Velocity profiles of 2.11-mm particles
suspended in (c) water and (d) blood. (e and f) Total weighted particle count per segment
Pithsegment as a function of the normalized y-position for (e) water and (f) blood.
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2.2.4 Defining Margination
Figures 2-6(a) and 2-6(b) show the number of particles tracked as a function of the
normalized y-position in both water and blood, respectively. The Reynolds number is
calculated to be approximately 0.018, suggesting that viscous forces are dominant in
relation to inertial forces and that the flow is laminar. In each case, a higher particle count
was recorded close to the centerline. This can be explained by the velocity profile for
pressure-driven flow through the channel, where the velocity is higher closer to the
centerline. Figures 2-6(c) and 2-6(d) show the actual velocity profiles (x-direction)
obtained by tracking the velocity of individual particles in water and blood, respectively.
A parabolic velocity profile was recorded in the water case, as expected for a simple
Newtonian fluid, whereas the blood case showed a profile closer to that of a plug-flow. The
formation of a CFL and the higher concentration of RBCs near the centerline likely
contributed to this profile. Such a blunted, plug-flow velocity profile for the blood
experiment was first reported by Goldsmith and Spain experimentally (Goldsmith and
Spain 1984). Higher velocities near the centerline will naturally lead to higher particle
count since more particles are transported through the channel in a given time and for a
uniform dispersion. To correct for the actual velocity profiles, the particle count has been
weighted according to the particle velocities:

Pi th segment 1,10  

where

 

j 1, n

v x ,max
v x, j

(2-3)

Pith -segment is the total weighted particle count for the ith segment, u x ,max is the

maximum particle velocity across the channel, u x , j is the velocity of the jth particle within
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the ith segment, and n is the total number of particles within the ith segment. Effectively,
each particle in a given segment is assigned a weighted value. Equation 2-1 is set up to
correct for the intrinsic velocity profile, where particles found closer to the wall always
move at a lower velocity and consequently fewer particles are recorded closer to the wall
relative to the center. Using Equation 2-3, particles moving at a slower speed will carry
larger weights than fast-moving particles. For instance, for a vx,max of 1 mm/s, a particle
moving at 0.1 mm/s near the wall will have a weighted value of 10 whereas a particle
moving at 0.9 mm/s near the center will have a weighted value of 1.11. Further, this method
also corrects for any difference in actual velocity profile under different experimental
conditions, such as suspending medium and wall shear rates. The use of this method is
further supported by Figures 2-6(e) and 2-6(f), which show the weighted particle counts
for different segments across the channel for water and blood, respectively. In the case of
water, no preferential accumulation in the near-wall segments was observed, whereas the
blood case clearly showed higher weighted particle counts in the segments nearest to the
walls. Such trends are not so apparent in the original particle counts before velocity profile
correction (i.e. Figures 2-6(a) and 2-6(b)).
In the literature, several definitions for margination propensity exist. In adhesion
studies, the fluorescence intensity of adhered particles was directly correlated to the
number of particles marginated. The higher the fluorescence intensity, the higher the
margination propensity. In simulation studies, where the exact center of mass of particles
is known, margination is conveniently defined as the number of particles at a given
characteristic distance from the wall (e.g., the cell-free layer thickness or adhesion
distance) (Kumar and Graham 2012, Reasor, Mehrabadi et al. 2012, Lee, Choi et al. 2013,
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Müller, Fedosov et al. 2014, Müller, Fedosov et al. 2015, Vahidkhah and Bagchi 2015). In
this study, each segment width is ~9.5 μm, which is close to the cell-free layer thickness as
shown in Figure 2-1(a). Thus, we define the “margination parameter” as:
M 

P1st segment  P10 th segment

P

i
i th segment 1,10 

(2-4)

with a total of 10 segments and the fact that two of the segments are close to the wall, if
there is no margination and an even distribution of particles then M should be equal to 0.2,
as 20% of the total number of particles should be found near the channel sidewalls. M is,
fundamentally, the percentage of particles that are in the CFL, after weighting, and that,
therefore, have marginated (as defined by this study). An M value of 0.2 or 20% is
equivalent to an even distribution of particles and is expected for the control experiments
using water. Figure 2-6(e) shows a typical plot for a water experiment. Each segment has
an approximately equal total weighted particle count and the M value of this plot is ~0.20,
as expected for a water experiment. Values that are larger than this indicate marginating
behavior. As shown in Figure 2-6(f) with blood as the suspending medium, segments 1 and
10 have higher total weighted particle counts compared to the rest of the channel. In fact,
this particular plot has an M value of ~0.33, suggesting margination.
All near-wall particles (particles in segments 1 and 10) were manually checked in
order to ensure the accuracy of the final results. While the automated tracking code greatly
speeds up particle tracking and saves many hours of manual work, it is nevertheless
important to ensure that no out-of-focus or false particles exist in the near-wall regions, by
width. Particles in the regions nearest to the wall are considered to be marginating particles.
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Because there are far fewer particles near the walls as a result of the velocity profile of the
fluid, each particle in these regions has a very large impact on the results based on the
chosen analysis methodology. Mistracked particles here can have large impacts on the M
value by nature of their high weighting due to their low velocity as a result of being close
to the wall. Particles in or nearer to the center of flow are, in contrast, very numerous and
the manual checking of all of these particles would take much longer for little effect since
these particles each have a very low weight. As such, only particles in segments 1 and 10
were manually checked.
For each experimental condition, a total of 3000 particles were analyzed to ensure
the results are statistically significant. The average and standard deviation of the
margination parameter, M, was calculated based on every 1000 particles tracked. This large
number of particles was important because there existed significant standard deviations
when only 100 particles were tracked whereas the tracking of 1000 particles was shown to
reduce the standard deviations by anywhere from 289 to 692%. These standard deviation
values for the 100 and 1000 particle cases are shown in Table 2-1 and correspond to the
typical M values at the device outlet for each particle size/suspending medium in Figure 27(c).
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Table 2-1: Average standard deviations of the margination parameter (M) calculated
based on 100 and 1000 particles in water and blood and for different particle sizes.
Standard deviation of the margination parameter (M)
Water

Blood

Diameter (µm)

100 particles

1000 particles

100 particles

1000 particles

0.53

0.0483

0.0111

0.0511

0.0112

0.84

0.0434

0.00627

0.0504

0.0133

2.11

0.0458

0.00684

0.0567

0.0196

2.3 Results and Discussion
2.3.1 Effect of Suspending Medium: Water vs. Blood
Figure 2-7(a) shows the margination parameter, or M, as a function of x (see Figure
2-1(b)), the distance from the inlet, for three different sizes (0.53 μm, 0.84 μm, and
2.11 μm) in water. At the channel inlet (x = 0 mm) in water, all three particle sizes showed
an M-value close to 0.2, indicating that the particles were evenly distributed after velocity
gradient correction and that there was no margination. The M-value at x = 10 mm in water
was also calculated for each of the particle sizes studied. Interestingly, both the 0.84-μm
and 2.11-μm particles showed an M-value lower than 0.2. This may be explained by
sedimentation, where settling velocities are dependent on particle size to the second power.
Using the Stokes-Einstein equation (Einstein 1905) (Re = 0.018 << 1), settling velocities
were estimated to be 0.459 μm/min, 1.15 μm/min, and 7.27 μm/min, for the 0.53-μm, 0.84μm, and 2.11-μm particles. Given the parabolic velocity profile, particles close to the wall
are traveling at a significantly slower speed relative to particles near the centerline and,
45

thus, particles closer to the wall have a longer residence time and are more prone to
sedimentation. As only the middle-plane (z ≈ 0) was imaged, settling particles would
become out-of-focus and were therefore not recorded by the particle tracking code. While
the density of the medium may be matched with that of the particle to mitigate
sedimentation and thus negate these effects, this approach has not been pursued in this
study because such density differences may also exist for actual drug carriers and possible
sedimentation effects should not be neglected.
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Figure 2-7: Margination parameter (M) for different sizes of particles: (a) suspended in
water at the inlet (x = 0) and at outlet (x = 10 mm); (b) suspended in water and blood,
respectively, at x = 0. (c) suspended in blood at different channel positions (x). For (a-c),
apparent wall shear rate = 61 s-1; (d) Margination parameter (M) of 0.53-μm particles
suspended in blood at varying flow rates at the outlet (x = 10 mm).
The distance required to establish a fully developed flow in a microfluidic device
is estimated to be 52.2 μm for water using the following equation and a calculated Reynolds
number of 0.018 for the current experiment (Ahmad and Hassan 2010):
xe
0.55

 0.065 Re
L 0.13 Re 1
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(2-5)

where xe is the entrance length from the inlet that is required in order for flow to be
considered fully developed and L is the characteristic length, or, in this case, the width of
the channel (95 µm). Equation 2-5 assumes the fluid is a homogeneous Newtonian fluid,
which is valid for water but not for blood. Figure 2-7(b) compares the M-value of three
different sizes of particles at the inlet (i.e., x = 0) where the particles are suspended in water
and blood. For all of the particle sizes studied, the M-value in the blood case is lower than
that for water, suggesting that fewer particles were found close to the channel wall at the
entrance in blood. However, as shown in Figure 2-7(c), the M-values downstream at x =
2.5 mm have returned to those observed in water (~0.2). We hypothesize that the reduction
in M-value at the entrance is associated with an entrance flow effect as the blood-particle
suspension is perfused through the tubing into the 3-mm diameter inlet and the microfluidic
channel (Figure 2-1(b)). Blood is a non-Newtonian fluid and the flow is heterogeneous so
the distance for establishing a fully developed flow is likely to be larger for blood than for
water. Indeed, as predicted by simulations by Katanov, Gompper and Fedosov, the distance
required in order for the CFL to fully develop is on the order of 2.4 mm for our
microchannel, further supporting the experimental observations of this study (Katanov,
Gompper et al. 2015). Furthermore, this experimental observation has two important
implications. First, it implies the usual, implicit assumption of a uniform dispersion of
particles at the entrance of a microfluidic device or other experimental system may not be
true. Second, the presence of a flow constriction, while not a requirement for margination
to occur, may have a non-negligible effect on particle margination. Since most microfluidic
devices feature a constriction where fluid enters the channel from a larger inlet punch,
results could be affected. It is therefore important to collect data at not only a downstream
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channel location but also near the inlet to ensure an accurate interpretation of the results.
The exact effect of flow constrictions is beyond the original scope of this paper. This
experimental observation has important implications on drug delivery in vascular
networks, where many different geometries and constriction shapes are possible. The
potential effects of constriction geometry on margination may be significant and warrant
further investigation in a future study.
2.3.2 Margination Velocity and Effective Diffusivity
Direct tracking of particles enables the analysis of velocity in not only the flowdirection (x) but also across the channel width (y-direction), which is of direct relevance to
margination. In fact, margination velocity and the corresponding standard deviation have
been reported in simulation studies by Kumar and Graham where the exact particle
positions were known (Kumar and Graham 2011, Kumar and Graham 2012). None of the
existing experimental studies have reported these values. Figures 2-8(a) – (f) show the yvelocity (uy), or margination velocity, of individual particles as calculated from direct
particle tracking in water and blood, respectively. It should be noted that these uy values
are averaged per particle and that a positive uy corresponds to the movement of a particle
towards either wall of the channel whereas a negative uy indicates that a particle is moving
towards the center of the channel. The uy is calculated from the center of mass of the particle
based on the brightness of the pixels. Briefly, we first weight each pixel by its relative
brightness and then find the center of mass by finding the center of brightness. This gives
us the center of the particle with a subpixel resolution and we can then calculate the yvelocity of the particle from frame to frame. In fact, the relatively large size of any blurred
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particle image gives more pixels to calculate the center of the particle and increases the
precision on calculating the position.

Figure 2-8: (a–f) Representative plots of average y-velocities for individual particles in
water or blood: (a and b) 0.53 mm, (c and d) 0.84-mm, and (e and f) 2.11-mm particles.
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For all particle sizes studied, there is a larger spread in uy in blood compared to
water as the suspending medium. The standard deviation in uy, denoted as u 'y , was
calculated to be on the order of 9 μm/s for water (averaged over all three particle sizes)
versus ~16 μm/s for blood, as shown in Table 2-2. The larger u 'y -value in the blood case
is attributed to the collisions between particles and blood cells, which are absent in the
water case. However, no noticeable difference in the u 'y values were observed among
different particle sizes, probably because of the relatively short travel distance in ydirection, as limited by the field of view (205 by 205 μm). Further, the translational
diffusivities of particles in water and blood cases were estimated by plotting the meansquare displacement as a function of time, as shown in Figures 2-9(a) and 2-9(b), and
calculating the slope (s), where Dy = s/2. A relatively large error arises from the spatial and
temporal limitations of our imaging system. Also, red blood cells can obscure some of the
fluorescent signal of the particles. Despite the relatively large error in determining the
particle position at short time scales, the calculated values for the water cases are of the
same order of magnitude as the Brownian diffusivities calculated using the StokesEinstein-Sutherland equation (Sutherland 1905). As expected, the smaller the particle size,
the higher the diffusivity in water. The higher experimental values may be caused by shearinduced diffusion (Lopez and Graham 2007). In the blood cases, the effective diffusivities
are all on the order of 15 μm2/s, much higher than those measured for the water cases (on
the order of 2-5 μm2/s), as shown in Table 2-2. Like u 'y , this is probably caused by the
collisions between particles and blood cells. Interestingly, in blood, the larger the particle
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size, the higher the effective diffusivity, suggesting collisions, instead of thermal motions,
are a predominant factor for margination.
Table 2-2: Experimental diffusivities and standard deviations of u y versus particle size
u 'y (µm/s)

Size (µm)
0.53
0.84
2.11

Water
9.30 ±0.23
9.34 ±0.70
7.10 ±1.44

Experimental Diffusivity (µm2/s)

Blood
15.44 ±1.45
16.16 ±0.80
17.48 ±0.74

Water
4.91 ±0.78
4.40 ±0.17
1.88 ±0.14

Blood
14.20 ±1.96
14.87 ±2.34
15.42 ±1.15

Figure 2-9: Mean square displacement as a function of time for 2.11 μm particles in: (a)
water and (b) blood. Theoretical lines (yellow) on both plots have a slope equal to two
times the Brownian diffusivity, which is calculated to be ~0.6 μm2/s using the StokesEinstein-Sutherland equation. From data fitting, the effective diffusivities were estimated
to be ~1.9 μm2/s and ~15.4 μm2/s for water and blood, respectively.
2.3.3 Effect of Particle Size
Using the M-values at x = 2.5 mm as benchmarks, the 2.11-μm particles showed the largest
change in M-value and thus the highest margination propensity, with a 45% increase
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relative to the case of an even distribution of particles, followed by the 0.84-μm particles
and the 0.53-μm particles. Therefore, larger particle sizes were found to result in a higher
margination propensity. The 0.53-μm particles showed similar M-values close to 0.2 at x
= 2.5 mm and 10 mm, suggesting there is no margination for this particle size once the
flow is fully established. This is in agreement with the findings from adhesion studies
(Decuzzi, Gentile et al. 2007, Gentile, Chiappini et al. 2008, Gentile, Curcio et al. 2008,
Charoenphol, Huang et al. 2010, Doshi, Prabhakarpandian et al. 2010, Namdee, Thompson
et al. 2013, Tan, Shah et al. 2013) as well as a recent direct particle tracking study by
D’Apolito et al. (D'Apolito, Tomaiuolo et al. 2015), where two spherical particle sizes (1
μm and 3 μm) were investigated. It is conjectured that larger particles interact more readily
with RBCs and, as a result of their frequent collisions with RBCs, are propelled toward the
walls of a blood vessel sooner than smaller particles, which have less frequent interactions.
Zhao et al. put forward an equation to calculate the distance required for a particle to reach
the CFL, or the “margination distance” (Zhao, Shaqfeh et al. 2012):

W 
u 
 4
X 
Dy

2

(2-6)

where u is the average flow-direction velocity, w is the channel width and Dy is the
diffusivity in the y-direction. Using effective diffusivities estimated experimentally
(Chapter 2.3.2), the margination distance is calculated from Equation 2-4 to be on the order
of 7.5 mm. Since the M values are close to 0.2 at x = 2.5 mm, the M values at x = 10 mm
likely reflect completed margination.
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2.3.4 Effect of Flow Rate
As discussed in Section 1, two opposite trends have been reported for the effect of
flow rates using particle adhesion to assess margination (Charoenphol, Huang et al. 2010,
Namdee, Thompson et al. 2013). While adhesion and margination are related, evaluating
margination based on the number of adhered particles could be further complicated by
factors such as hydrodynamic drag, densities of ligands and receptors grafted onto both the
particle surface and the wall channel, particle shape and contact orientation, and particle
size relative to the CFL (Carboni, Tschudi et al. 2014, Müller, Fedosov et al. 2014,
Vahidkhah and Bagchi 2015). Particles may have detached from the wall due to collisions
with blood cells or increasing wall shear rate. This may explain why the margination
propensity decreases as a function of increasing flow rate (Namdee, Thompson et al. 2013).
Further, only particles that come into direct contact with the wall are being measured. This
method does not account for particles that marginate to the CFL but do not adhere to the
wall. As a result, larger particles may be predisposed to adhere more readily due to their
larger size relative to the CFL. In this study, the margination parameter (M) was calculated
based on the actual velocity profile and normalized by the total particles perfused through
the microchannel for a given time. This analysis method is less susceptible to any variation
in the actual particle number concentration. It also offers a fairer comparison between
different flow rates because the total number of particles perfused through the device
increases as a function of increasing flow rates (for a given number concentration and
perfusion time). As shown in Figure 2-7(d), the higher the flow rate, the higher the Mvalue. This is probably caused by higher collision frequencies between particles at higher
flow rates. This explanation is consistent with the observation that the standard deviation
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of particle velocity in the y-direction (uy) increases as a function of increasing flow rates,
as shown in Table 2-3.
Table 2-3: Standard deviation of uy ( u 'y ) for varying flow rates in blood
Wall shear rate (s-1)

u 'y (μm/s)

33

10.27

67

14.22

133

23.68

2.4 Conclusions
To summarize, the margination of particles in blood was characterized by directly
tracking the spatial distribution of particles passing through a microfluidic channel at
different physiologically relevant flow rates. A margination parameter, M, was defined to
quantify margination propensity after correcting for the velocity gradient in the flow
direction (x). A benchmark value of 0.2 was established through a control experiment,
where the particles were suspended in water with no margination. When suspended in
water, particles close to the channel wall with longer residence time tended to settle,
leading to relatively fewer particles found near the wall at the outlet (x = 10 mm) and
consequently an M-value smaller than 0.2 for the 0.84-μm and 2.11-μm particles. When
suspended in blood, the M-values for all particle sizes at the entrance (x = 0) were smaller
than those in water. This is probably due to non-fully developed flow and constriction as
the blood-particle mixture entered from the tubing and inlet into the microfluidic channel.
The largest particles (2.11-μm) showed highest margination propensity, followed by the
0.84-μm particles, whereas the 0.53-μm particles showed no margination. While the results
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cannot be compared directly to other studies because of differences in experimental
conditions, the observed trend is qualitatively consistent with results reported by earlier
experimental and simulation studies.
In addition to M, the particle velocity in the margination direction (uy) was
characterized experimentally for the first time. Compared to the case of water, all particle
sizes showed a larger fluctuation in uy when suspended in blood. Likewise, a higher
effective diffusivity, on the order of 15 µm2/s, was also observed in all the blood cases
relative to the water cases, which vary from 2 – 5 µm2/s. The larger fluctuations in vy and
higher effective diffusivity in blood are probably caused by the collisions between particles
and blood cells, consistent with arguments put forward by earlier simulation studies
(Kumar and Graham 2012, Kumar and Graham 2012, Kumar, Henríquez Rivera et al. 2014,
Vahidkhah and Bagchi 2015). Further, the calculation of M accounts for the actual velocity
gradient and the absolute total number of particles passed through the channel, offering a
more robust way to compare data collected at different flow rates. An increase in flow rate
led to both a larger M-value at the exit and a higher effective diffusivity, confirming
experimental results by Charoenphol et al. (Charoenphol, Huang et al. 2010). However,
limitations of this study do exist. Particle tracking is limited by the spatial and temporal
resolution of the imaging system, the relatively small field of view, and the presence of
RBCs, which, at higher hematocrits, can absorb/scatter light and make the direct tracking
of fluorescent particles challenging. No significant difference in terms of the margination
velocity and diffusivity was observed among different particle sizes when suspended in
blood. Second, this study focuses on the distribution of particles within the channel and
does not account for the transport of particles through the spacing between endothelial
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cells, which typically varies from 0.3 to 4.7 μm (Hashizume, Baluk et al. 2000). Large
particles may exhibit more margination propensity but may not be small enough to pass
through the spacing to reach the tumor site. Finally, according to Wiedeman (Wiedeman
1963), the length of an arteriole in-vivo is only approximately 1 mm, with branches of other
arteries every 0.2 mm so the length scale is not as close to in-vivo as it could be. All in all,
this paper investigated the effect of particle size and shear rate on margination propensity
based on the particle distribution, velocity (both along and transverse to the flow direction)
and effective diffusivity. The findings suggested that margination is primarily caused by
the collisions between particles and blood cells, instead of Brownian motion.
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3 The Margination of Particles in Areas of Constricted Blood Flow
3.1 Introduction
Since 1997, stroke has been a leading cause of death globally (Murray and Lopez
1997, Wang 2016). While stroke in the gray matter of the brain is well-known,
approximately 30% of all strokes occur in the white matter (Rosenzweig and Carmichael
2013). However, unlike the rest of the brain where the diameters of blood vessels can range
from 15 to 140 μm, with an average diameter of 30 μm, blood vessels in the white matter
of the brain are arterioles and have diameters of approximately 100 to 200 μm (Alexander
and Putnam 1938, Rowbotham and Little 1965, Harnarine-Singh, Geddes et al. 1972). The
narrowing of arterioles from the development of a stenosis is termed arteriolosclerosis and
can cause strokes in the white matter, which can lead to dementia and motor function
impairment amongst other complications (Rosenzweig and Carmichael 2013).
Furthermore, lacunes are cavities that result from ruptured arteries of around 100 µm as a
result of arteriosclerosis and can lead to death (Fisher 1965, Fujiwara, Ishikawa et al. 2009)
and arteriolosclerosis can also be responsible for hypertension, chronic kidney disease and
left ventricular hypertrophy (Kanbay, Snchez-Lozada et al. 2011). Arterioles are a very
important part of the vasculature but have major differences from both tiny and large
arteries.
While blood behaves as a nearly Newtonian fluid in large blood vessels, in vessels
with smaller diameters, such as the aforementioned arterioles, blood rheology becomes
more complex and a phenomenon known as margination can occur (Fedosov, Caswell et
al. 2010). In these smaller blood vessels, typically having diameters less than about 300
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µm (Pries, Secomb et al. 1996, Lim, Ober et al. 2012, Carugo, Capretto et al. 2013),
interactions with red blood cells (RBCs) in the center of the vessel can cause particles to
migrate to the periphery of the blood vessel, or marginate (Kumar and Graham 2012).
While white blood cells (WBCs) were the first to be observed to marginate, drug-carrying
microparticles were subsequently found to be able to also marginate (Dutrochet 1824,
Segré and Silberberg 1962). Margination of drug-carrying particles is important because
marginated particles are near the wall and will be more effective in delivering their drug
cargo. For all particles, the extent of this margination depends upon particle size, among
many other characteristics of the particles and also the blood (Kumar and Graham 2012,
Carboni, Tschudi et al. 2014). However, while factors such as size, shape, and hematocrit
and their effects on margination propensity have been investigated, the effects of stenoses
on margination are largely unknown.
A number of studies have investigated drug delivery to a site of stenosis using
specific attributes of the stenosis, such as the enhanced local shear (Holme, Fedotenko et
al. 2012, Korin 2012, Korin, Kanapathipillai et al. 2013, Saxer, Zumbuehl et al. 2013). In
this case, the margination of particles becomes even more important because shear is at a
maximum for marginated particles. However, stenoses can have various geometries and
there is a lack of understanding of the effects of stenosis geometry on the margination of
drug particles, especially in the smaller arterioles. Additionally, while many studies have
investigated the effects of various geometries of flow constrictions and expansions on red
blood cell motion (Li, Fang et al. 2004, Zhao, Marhefka et al. 2008, Fujiwara, Ishikawa et
al. 2009, Srivastava, Rastogi et al. 2010, Sousa, Pinho et al. 2011, Yaginuma, Oliveira et
al. 2011, Ha and Lee 2013, Faustino, Pinho et al. 2014, Hall and Calt 2014, Monteiro,
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Taboada et al. 2014, Pinho, Rodrigues et al. 2014, Xiao, Chen et al. 2014, Dimakopoulos,
Kelesidis et al. 2015, Akbar 2016, Kim, Antaki et al. 2016, Taboada, Monteiro et al. 2016,
Vahidkhah, Balogh et al. 2016, Zaman, Ali et al. 2017) and on platelet motion (Zhao,
Marhefka et al. 2008, Kamada, Tsubota et al. 2011, Li, Ku et al. 2012, Bark Jr and Ku
2013, Ha and Lee 2013, Tovar-Lopez, Rosengarten et al. 2013), the effect of stenosis
geometry on the margination of drug-carrying particles remains largely unexplored. It was
previously observed that in regions of flow constriction the margination propensity of
microparticles may be affected (Carboni, Bognet et al. 2016). Despite these findings, it is
unclear as to how exactly the geometry of a stenosis, which includes both an area of
constriction and of expansion, affects microparticle margination. This is also particularly
relevant for in-vitro margination studies, all of which tend to include flow constrictions
and expansions in their experimental apparatus as a result of constrictions that are present
in tubing-to-tubing or tubing-to-inlet-port connections.
In this study, multiple channel geometries were investigated in-vitro via the use of
microfluidic devices. The effects of occlusion percentage, constriction length, and degree
of eccentricity of the entrance and exit of the stenosis were investigated and their effects
on particle margination were quantified using direct particle tracking.
3.2 Methodology
3.2.1 Materials
Defibrinated bovine blood (Lampire Biological Laboratories, Inc., Pipersville, PA)
was adjusted to 35% hematocrit using the previously established washing procedure.
Fluorescent polystyrene spheres of 2.11 μm diameter were suspended in the blood and used
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as model particles (Spherotech Inc., Lake Forest, IL). This particle size was chosen because
it displayed the most margination in a previous study and, thus, would be the most affected
by subtle changes in the constriction and expansion geometry (Carboni, Bognet et al.
2016). For microfluidic device fabrication, polydimethylsiloxane (PDMS) pre-polymer
and curing agent were used (Silgard 184 Silicone Elastomer Kit, Krayden Inc., Denver,
CO).
3.2.2 Microfluidic Device Design
Microfluidic device designs were produced using AutoCAD software. Three
geometric parameters, namely percent occlusion, constriction length, and eccentricity,
were explored and varied one at a time. Percent occlusion is defined the as the ratio of the
channel width at the constricted area compared to the non-constricted area. Three different
percent occlusions (25%, 50%, and 75%) as illustrated in Figure 3-1(a) were studied. The
second parameter is constriction length and is defined as the distance between the end of
constriction and the beginning of the expansion. Four constriction lengths, ranging from
50 μm to 10 mm were investigated (Figure 3-1(b)). The third parameter is eccentricity,
which describes the gradualness of channel constriction and expansion, as illustrated in
Figure 3-1(c). Mathematically, eccentricity at the constriction and expansion was
calculated according to the formula for the eccentricity of an ellipse:
𝑏2

𝜀 = √1 − 𝑎2

(3-1)

where ε is the eccentricity and a and b are the length of the semi-major and semi-minor
axis of the ellipse, respectively. A maximum eccentricity of 0.99 was selected to limit the
transition length required to establish full constriction. All devices used in this study have
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a channel depth of 100 μm and a channel width of 100 μm in the non-constricted area. As
shown in Figure 3-2(a), the channel is 10 mm long both before and after the constricted
area, while the constriction length varies. The distance required for a particle to fully
marginate, or the margination distance, was calculated to be 7.5 mm, using a formula
proposed by Zhao et al. (Zhao, Shaqfeh et al. 2012) and experimentally determined particle
diffusivity (Carboni, Bognet et al. 2016). A 10-mm length was therefore chosen to ensure
that margination reached completion before the introduction of a constricted area.

Figure 3-1: Device designs at the constriction, with the later expansion 10 mm downstream
mirroring these geometries (a) Variable occlusion percentage (b) Variable constriction
length with mirrored expansion after the given distance and (c) Variable eccentricity.
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Figure 3-2: (a) Design of a typical device with 10 mm segments before and after a 10 mm
constricted, middle segment (devices with constriction length variations had shorter
constricted segments) (b) Close-up of the first red box, showing imaging positions 1 and 2
(c) Close-up of the second red box, showing imaging positions 3 and 4.
3.2.3 Device Fabrication
Microfluidic devices were fabricated from a commercially-obtained silicon wafer
master (FlowJEM, Toronto, Canada) using PDMS and following established procedures.
Briefly, elastomer base and curing agent were mixed in a 10:1 ratio. The resultant mixture
was degassed for 10 minutes to remove air bubbles and placed in an oven and allowed to
cure. The devices were cut out and punched to form an inlet and an outlet and then plasma
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bonded (Basic Plasma Cleaner PDC-32G, Harrick Plasma, Ithaca, NY) to a glass coverslip
slide (#1.5, Thermo Fisher Scientific Inc., Waltham, MA) using the custom procedure
developed in Chapter 2.
3.2.4 Experimental Apparatus and Considerations
Blood containing the fluorescent 2.11-µm spherical particles was pumped through
microfluidic devices using a pressure-driven pump system equipped with a flow controller
(Fluigent Inc., Villejuif, France). This pump system, instead of a syringe pump, was used
for better flow rate control (Carboni, Bognet et al. 2016). The fluid was pumped through
the microfluidic device at a physiologically relevant average velocity of 1 mm/s in the nonconstricted regions which corresponds to a volumetric flow rate of 0.60 µL/min and an
apparent wall shear rate of 70.9 s-1 (Klug, Lessin et al. 1974, Pries, Secomb et al. 1995,
Kubota, Tamura et al. 1996, Cai, Fan et al. 2012). The Reynolds number (Re) is defined
as:

Re 

Wu
Q


WH

(3-2)

where 𝜌 is the density, W is the channel width, 𝑢̅ is the mean fluid velocity, µ is the
(dynamic) viscosity of the fluid, Q is the volumetric flow rate, and H is the depth (or height)
of the channel. The Reynolds number compares inertial to viscous forces and was
calculated to be approximately 0.030, suggesting that viscous forces dominate inertial
forces and that the flow is laminar for all device geometries. Alternatively, Equation 3-2
can be written in terms of volumetric flow rate (Q) and channel depth (H). The volumetric
flow rates and channel depth are kept constant in all experiments and the Re number
therefore remains constant if a Newtonian fluid is assumed. However, this simplified Re
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calculation does not take into account the shear-thinning nature of blood. A generalized
Reynolds number for a power law fluid was defined by several authors (Metzner and Reed
1955, Madlener, Frey et al. 2009) as:

Re genPL 

w n u ( 2 n )
K ((3n  1) /(4n)) n 8 ( n 1)

(3-3)

where n is the power law index of the fluid and K is the flow consistency index of the fluid.
Equation 3-3 reduces to Equation 3-2 for a Newtonian fluid with n = 1 and K = µ. Using
literature values for blood (n = 0.716 and K = 0.0171 Pa*s) (Elblbesy and Hereba 2016),
RegenPL was calculated to be ca. 0.020 and ranges between 0.024 to 0.044 for 75% to 25%
occlusion, respectively. Small Reynolds numbers like these imply that viscous forces are
dominant in the current experimental system.
For each device, a 60,000-frame (~7.5 minutes) time-lapse video was acquired using a
dry objective lens (40x) with a high-speed camera (Andor iXon Ultra 897 iX0897 EMCCD,
130 frames/s, Andor Technology Ltd., Belfast, UK) and an inverted fluorescence
microscope (Nikon Eclipse Ti-E, Nikon Instruments Inc., Melville, NY) with an
Epifluorescence source (Intensilight C-HGFIE, Nikon Instruments Inc., Melville, NY).
These time lapse videos were collected at four positions: (1) before the constriction, (2)
after the constriction, (3) before the expansion and (4) after the expansion. In each case,
the time lapses were collected 200 µm away from the respective geometric change to allow
for flow reestablishment. Figure 3-2(a) and Figure 3-2(b-c) show the areas of imaging for
each full-length (10 mm) constriction device, with Positions 3 and 4 located downstream
mirroring Positions 2 and 1, respectively. It should be noted that, for the case of variable
constriction length, videos at Positions 2 and 3 were not collected because the lengths
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studied were shorter than the viewing window and, as a result, videos at these positions
were impossible to obtain. As such, only the results at Position 1 and Position 4 were
recorded for these devices. After each time-lapse video was collected, the reservoir of
blood was gently shaken to keep the solution well mixed and the device was perfused at a
high flow rate (~8 μL/min) for approximately 2 minutes. After every 2-3 time lapses, the
entire system was flushed for 10 minutes before collection of the next time lapse.
3.2.5 Image Analysis: Particle Tracking
MATLAB® was used to analyze the time-lapse videos. The fluorescent particles
were tracked using code developed in-house. Similar to a previous study, the tracking code
consists of three steps: first, a background correction was performed to remove any bright
pixels associated with particles adhered to the bottom of the channel. Second, the position
and size of all particles were then calculated using a gradient-based method. The calculated
particle size was used to eliminate out-of-focus particles based on their apparent larger size.
Lastly, the positions of all remaining particles were tracked as a function of time to
calculate velocities.
Different from last time, some near-wall particles were found to be tracked, lost
and tracked again, and sometimes again afterward as well. This was termed “doubletracking” or “triple-tracking” and new MATLAB® code was developed to correct for these
phenomena. In the code, particle frame numbers and y-positions were compared – particles
that shared a very close frame number and y-position were removed as they were highly
likely to be double- or triple-tracked. The code removed the first track from particles that
were detected to have been doubled-tracked and the first and second tracks from particles
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that were detected to have been triple-tracked. The last track was kept for these particles
since it was the longest and thus most accurate track.
Since this code had an impact on results, the results from Chapter 2 were rerun
using this new code. However, no differences in the margination parameters were found.
As a result, the double- and triple-tracking phenomena were concluded to only have
occurred starting in this Chapter’s experiments and were likely a result of using new
software (Andor SOLIS was used in Chapters 3 and 4 whereas Andor IQ was used in
Chapter 2) to track the particles or the use of a slightly higher microscope gain in this
Chapter.
3.2.6 Quantifying Margination
The methodology for the quantification of margination propensity is detailed in a previous
study by the authors (Carboni, Bognet et al. 2016). Briefly, the channel in each time-lapse
video was first split into 10 equally-spaced segments and particles were tracked and
counted in each of the 10 segments. The weighting by velocity was done to account for the
naturally higher particle count near the center of the channel due to the higher velocity of
the fluid and, therefore, throughput of particles. Since more particles will be seen nearer to
the center of the channel where the velocity is at a maximum and more particles will be
observed over a given time for a uniform dispersion, weighting the particles based on their
velocities allows for velocity profile normalization. This weighting is given by the
following equation (Carboni, Bognet et al. 2016):

Pi th segment 1,10  
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j 1, n

v x ,max
v x, j

(3-4)

where

Pith -segment is the total weighted particle count for the ith segment, vx,max is the

maximum particle velocity across the channel, vx, j is the velocity of the jth particle within
the ith segment, and n is the total number of particles within the ith segment. From Equation
3-4, each particle in a segment is assigned a weighted value and slower particles will be
weighted more heavily. We next define the margination parameter, M, as:
M 

P1st segment  P10 th segment

P

i
i th segment 1,10 

(3-5)

Equation 3-5 allows for results that are easily interpretable and comparable. Assuming an
even distribution of particles in a fluid where no margination occurs, such as water, M
should be equal to 0.20 because the weighting would result in each segment having 10%
of the total particle weight and two of the segments are adjacent to the channel wall. As
expected, an M of approximately 0.20 was found for a control experiment that was
conducted using water, as shown in Figure 3-3(a). Larger values of M are indicative of
marginating behavior and the magnitude of M can be compared between experiments to
quantify the effects of each of the geometrical changes studied on particle margination. For
each experiment, an average M was calculated after tracking and analyzing thousands of
particles and a one-way ANOVA with a Tukey comparison was run on the results to ensure
statistical significance.
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Figure 3-3: Margination Parameters at different positions for (a) water and (b) blood.
Percent occlusion: 50%; constriction length: 10 mm; eccentricity: 0. Asterisks denote
significance of a value from all others, asterisks with lines denote nonsignificance of the
grouped values from one another but significance from non-grouped values.
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3.3 Results
3.3.1 Effect of Position
For particles suspended in water, minimal changes in the margination parameter
were observed with varying position, as shown in Figure 3-3(a). A one-way ANOVA has
shown that none of these margination parameters are statistically significant from one
another (p > 0.05 in all cases). This is as expected since there are no particle-RBC
interactions in water and these values are all very close to the expected value of 0.20 for a
fluid with an even distribution of particles after velocity normalization. Figure 3-3(b)
shows the results for blood in the same device at various positions. A one-way ANOVA
shows that all of these values are statistically significant from one another (p < 0.05). The
margination parameter increases from Position 1 to Position 2 and from Position 2 to
Position 3. However, a decrease in M is observed from Position 3 to Position 4.
This trend was observed for all device geometries with the exception of the shorter
length devices (50, 100 and 200 µm) where Positions 2 and 3 are undefined. It was
considered that particles in the constriction are more difficult to track due to their faster
velocity and that this could in turn artificially inflate the margination parameter at Positions
2 and 3, leading to the observed increase from Position 1 to Position 2 and decrease from
Position 3 to Position 4. However, since the water results show no significant difference in
the margination parameter between positions it is likely that the blood results are not a
result of tracking difficulties and that, instead, the geometry is the cause of the change in
margination parameter from location to location. We hypothesize that particle-RBC
interactions - the driving force for margination (Kumar and Graham 2012, Kumar and
Graham 2012, Kumar, Henríquez Rivera et al. 2014, Vahidkhah and Bagchi 2015) - are
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significantly altered by the constriction and also by the expansion geometries. Effect of
Variable Occlusion Percentage
As shown in Figure 3-4, the M value increases with an increasing occlusion
percentage. These results were confirmed to be significant via the use of a one-way
ANOVA (p < 0.05). The degree of occlusion appears to have a large effect on the M value.
For instance, increasing percent occlusion from 25% to 75% results in a 41.6% increase in
the M value. Blood is considered to be an incompressible fluid and the mean velocity in
the constricted region will change due to the reduction in the cross-sectional area of the
channel, as given by the continuity equation:
Q  uA

(3-6)

where Q is the volumetric flow rate, 𝑢̅ is the mean velocity of the fluid and A is the crosssectional area of the channel. For the same volumetric flow rate, a reduction in the crosssectional area of the channel results in a proportional increase in the velocity of the fluid.
An occlusion of 25%, 50% and 75% yield an increase in velocity by a factor of 1.33, 2 and
4, respectively. Other studies have linked higher shear rates to increased margination
(Charoenphol, Huang et al. 2010, Namdee, Thompson et al. 2013, Carboni, Bognet et al.
2016). This may be a result of enhanced RBC-particle interactions. These interactions,
which are between elastic and stiff particles and termed heterogeneous collisions, are
identified as a driving force for margination (Kumar and Graham 2011, Kumar and Graham
2012, Kumar, Henríquez Rivera et al. 2014). In atherosclerosis, for example, myocardial
infarctions are known to occur at percent occlusions above 70% (Pijls 2009, Holme,
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Fedotenko et al. 2012). However, the cutoff value for a stenosis to become life-threatening
is largely unknown for arterioles.

Figure 3-4: Variable percent occlusion device results. Length: 10 mm; eccentricity: 0.
Asterisks denote significance of a value from all others, asterisks with lines denote
nonsignificance of the grouped values from one another but significance from non-grouped
values.
3.3.2 Effect of Variable Constriction Length
As shown in Figure 3-5, the M value increases with increasing constriction length.
A one-way ANOVA showed that 50 and 200 µm lengths were significantly different but
that 50 and 100 and 100 and 200 µm lengths were not. This demonstrates that, while length
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does have an effect on the M value, the effect is difficult to see in 50 to 100 µm intervals.
While longer constrictions do allow more time for further particle margination to occur,
even a short length of 200 µm results in 14% enhanced margination compared to a length
of 50 µm. As such, it is possible that there are other interactions, such as between particles
and RBCs as the constriction and/or expansion occurs, that could result in such enhanced
margination despite such a small difference in constriction length. This hypothesis is
further supported by experimental results showing the effects of just the constriction on the
M-value, where the M-value was found to increase in each case. In each experiment where
a video within the constriction was acquired and analyzed, just after the constriction the
M-value was found to increase. These results, combined with the results for variable
constriction length, suggest that margination may be slightly enhanced by the presence of
even a short constriction. While the lengths of cerebral arterioles in humans are known to
be on the order of 3 mm (Aydin, Rosenblum et al. 1991), the length of a typical
arteriolosclerotic region is not documented in the literature. Should it be on the order of the
length of a cerebral arteriole, however, then margination would be significant and would
fall somewhere between the values of the 200 µm length channel and the 10,000 µm length
channel.
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Figure 3-5: Variable constriction length device results. Percent occlusion: 50%;
eccentricity: 0. Asterisks denote significance of a value from all others, asterisks with lines
denote nonsignificance of the grouped values from one another but significance from nongrouped values.
3.3.3 Effect of Variable Eccentricity
The

eccentricity

of

the

occlusion

was

varied

between

a

sudden

constriction/expansion (N/A), a quarter-circle (0 eccentricity) entrance and an increasing
eccentricity (0.5, 0.75 and 0.99) to explore the effects that the shape of the entrance had on
particle margination. The results are shown in Figure 3-6. A one-way ANOVA showed
significance (p < 0.05) of the results for the 0 and 0.5 eccentricity, while the other values
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were insignificant from one another but significant in comparison to the 0 and 0.5
eccentricities. From these results, as the entrance and exit to and from the constricted area
become more and more gradual (eccentricity increases), margination was found to
decrease. However, interestingly, the sudden constriction/expansion device showed
significantly lower margination than the 0-eccentricity device. Indeed, the M-value for the
N/A eccentricity device was comparable to (and insignificant from) the M-values for the
0.75 and 0.99 eccentricity devices. These results for the N/A device, though puzzling, were
confirmed through multiple experiments.
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Figure 3-6: Variable eccentricity device results. Length: 10 mm; percent occlusion: 50%.
Asterisks denote significance of a value from all others, asterisks with lines denote
nonsignificance of the grouped values from one another but significance from non-grouped
values.
It is observed that the lower M-value at position 4 could be a result of the expansion
directly before it. The N/A eccentricity device had a much higher M-value at position 3, of
0.4157. However, at position 4, the M-value dropped to the outlet value of 0.3342 depicted
in Figure 3-5. Recalling that position 1 is 200 µm before the constriction, that position 2 is
200 µm after the constriction, position 3 is 200 µm before the expansion and position 4 is
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200 µm after the expansion, the M-values for positions 1 and 2 and for positions 3 and 4
should be the same if the geometry has no effect on particle margination since the distance
between these two sets of positions is very small. It was found that the N/A eccentricity
device had the largest increase in M-value from position 1 to position 2 and also the largest
decrease in M-value from position 3 to position 4 out of all of the variable eccentricity
devices. This suggests that the constriction and expansion areas had the largest effect on
margination in the N/A eccentricity device out of all other variable eccentricity geometries
and supports the hypothesis that the straight walls had a major albeit unexpected and
largely negative impact on the margination of particles in this geometry.
In literature, some studies observed a recirculating flow after a sudden expansion
(Sollier, Go et al. 2014, Dhar, Pao et al. 2016). This recirculating flow was investigated
for the N/A eccentricity device as a potential explanation for the unexpectedly low Mvalues observed. Recirculating flow was found to occur as a result of two competing lift
forces arising from inertia: a shear-gradient lift force and a wall-effect lift force for particle
Reynold’s numbers (Rep) greater than one, as given by the following equation:
a
Re p  Re 
W 

2

(3-7)

where a is the particle diameter and W is the width of the channel. For this study, Rep was
approximately 4.45x10-5, which is well outside of the range for recirculating flow.
Furthermore, no flow perturbations, such as a recirculating flow, were observed
experimentally in the N/A eccentricity geometry after reviewing time-lapse videos taken
at the constriction and expansion regions.
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To better understand the flow profile of the N/A eccentricity device, blood was
modeled as a power-law fluid in COMSOL software and the results are shown in Fig. 3-7.
Stagnant zones with no flow were clearly observed near the corners at the entrance and exit
of the constricted channel. Further, no recirculation was observed at the exit of the
constricted channel, consistent with the experimental observation. However, it should be
noted that blood is treated as a homogeneous fluid in the simulations. Such approach is
inadequate in capturing margination which originates from the interactions between RBCs
and particles. For future work, numerical models may be extended to offer insights into
experimental observations reported in this paper for varying stenosis geometries, especially
in the case of sudden constriction and expansion.

Figure 3-7: COMSOL model of the flow for various eccentricities.
3.4 Conclusions
To summarize, particle margination was quantified via the direct tracking of
fluorescent model particles in microfluidic devices having different constriction and
78

expansion geometries. A margination parameter, or M value, was calculated at different
locations as the particles enter and exit the constricted areas mimicking a stenosed blood
vessel. The higher the M-value, the larger the degree of margination. As a control
experiment, particles were suspended in water and pumped through the devices. No signs
of margination were recorded at all the positions imaged. In the case of blood, the M-value
increased after a constriction but decreased after an expansion, suggesting that channel
geometry has an important effect on particle margination. The effects of the degree of
occlusion (or percent occlusion), constriction length, and the gradualness of
constriction/expansion were further investigated. Increasing percent occlusion and
increasing constriction length increased particle margination. As the percent occlusion
increases, a higher shear rate will be present in the constricted region, which has previously
been shown to lead to enhanced margination (Charoenphol, Huang et al. 2010, Carboni,
Bognet et al. 2016).
As for the positive effect of constriction length on margination, it is attributed to:
(i) a longer residence time for longer constriction lengths and/or (ii) enhanced particleRBC interactions, which have shown to be the root cause of margination (Kumar and
Graham 2012, Kumar, Henríquez Rivera et al. 2014, Vahidkhah and Bagchi 2015). In
terms of the channel shape, a more gradual constriction/expansion region (with increasing
eccentricity) resulted in a lesser degree of margination, with the exception of a sudden
constriction/expansion geometry. No recirculating flows were observed experimentally or
COMSOL simulations. The exact reason is unclear and requires further numerical
modeling, such as particle dynamics simulations, which consider the discrete interactions
between particles and RBCs. All in all, this study reveals that the channel geometry has
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non-negligible effects on particle margination. However, percent occlusion, constriction
length and eccentricity are not well-defined and are not fully characterized in existing invivo studies. The findings of this paper call for a more detailed geometric characterization
of the stenosed areas in order to better understand the underlying physics.
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4 Effects of Pulsatile Blood Flow Patterns on Particle Margination
4.1 Introduction
It is well-known that blood flow is generally pulsatile in nature, characterized by
time-dependent variations in both pressure and flow rate (Pan, Wang et al. 2014). Existing
in-vitro experimental studies of particle margination utilize either pulsatile flow or a single
constant, steady flow rate when running experiments. While these studies commonly do
not cite their reasoning as to why they chose a particular flow rate, a study by Phibbs
(Phibbs 1966) and also a separate study by Goldsmith and Spain (Goldsmith and Spain
1984) found that there existed an enhanced concentration of WBCs near the periphery of
blood vessels in pulsatile flow when compared to the concentration in steady flow.
Furthermore, a later study by Xu and Wootton investigated the margination of platelets in
both pulsatile and steady blood flow and found increased platelet margination in pulsatile
vs steady blood flow, especially (Xu and Wootton 2004). They also concluded that
margination may develop more rapidly near the vessel wall in pulsatile vs steady flow
conditions (Xu and Wootton 2004).
However, this study utilized 3 mm diameter tubes as the experimental system. In
blood vessel or channel diameters above approximately 300 µm, the effects of individual
RBCs are negligible (Pries, Secomb et al. 1996, Lim, Ober et al. 2012, Carugo, Capretto et
al. 2013). Below this diameter, mechanical interactions between RBCs and walls cause the
RBCs to tend to focus towards the center of the channel, termed axial migration, and causes
significant non-Newtonian behavior (Bayliss 1959, Goldsmith and Mason 1961, Pries,
Secomb et al. 1996, Sankar, Nagar et al. 2015). The experimental system employed by Xu
and Wootton characterized a large blood vessel and does not take into account the axial
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migration of RBCs that is present in a smaller blood vessel. This focusing of RBCs towards
the center of the blood vessel has been observed by several modeling studies to lead to
heterogeneous interactions between RBCs and WBCs, which are thought to be a major
driving force for margination (Kumar and Graham 2011, Kumar and Graham 2012).
Further, the study in Chapter 2 produced results that experimentally supported the existence
of these particle-RBC interactions and their importance to margination (Carboni, Bognet
et al. 2016). Despite these unique mechanics and the importance of arterioles, especially
cerebral arterioles in white-matter stroke as described in Chapter 3 (Alexander and Putnam
1938, Fisher 1965, Rowbotham and Little 1965, Harnarine-Singh, Geddes et al. 1972,
Fujiwara, Ishikawa et al. 2009, Kanbay, Snchez-Lozada et al. 2011, Rosenzweig and
Carmichael 2013), almost no studies look at the effects of pulsatile flow in smaller arteries
and arterioles (Kanaris, Anastasiou et al. 2012).
As such, an experimental study of the effects of pulsatile vs steady flow in a smaller
blood vessel such as the current arteriolar geometry with a width of 100 µm was conducted.
The goal was to illuminate the effects on margination of pulsatile vs steady flow in smaller
arterioles and arteries. Furthermore, the effects of varying the frequency and amplitude of
the pulses were investigated. Exploring these variables and observing the degree of
margination produced by variations in each could lead to an isolation and better
understanding of the mechanisms by which pulsatile flow may cause enhanced
margination. This, in turn, could shed light on the degree of necessity in using pulsatile
flow in experiments that seek to employ the most accurate system possible for the purposes
of quantifying or investigating margination.
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4.1.1 Modeling Physiological Pulsatile Flow
Physiological pulsatile flow is modeled in a number of studies, with information on
the physiologically relevant range and shape of the pulsations (Chaturani and Palanisamy
1989). The simplest model for pulsatile flow was developed by Womersley in 1955 but
was for large arteries, not smaller arterioles (Womersley 1955, Elad and Einav 2009).
While some of the smallest arteries do not exhibit pulsatile flow because it is damped out
by the time it reaches them (Burton 1965, Charm and Kurland 1974), it is still present in
arterioles (Elad and Einav 2009).
The shape of physiological pulsatile flow can be modeled as a sine wave (Ku,
Giddens et al. 1985, Chaturani and Palanisamy 1989, Ojha, Ethier et al. 1990, Walker,
Johnston et al. 2014). The amplitude or flow rate of such a function can be taken as the
typical flow rate in the relevant blood vessel, in this case an arteriole. As for the frequency,
a number of studies mention different numbers, many even for the same or similar flow
conditions. A near-1 hz pulse frequency appears to be dominant but the only studies
available that mention frequency are the studies of larger channels. Bok et al. and Kahveci
and Becker, for example, utilized a pulse frequency of 60 pulses/minute, or 1 hz in their
experiments (Lee, Assadi et al. 1978, Kahveci and Becker 2015). However, a frequency of
approximately 0.27 hz was also used in a different large-channel experiment (Walker,
Johnston et al. 2014) as was a frequency of 2.9 hz (Ojha, Ethier et al. 1990). Finally, the
experiment by Xu and Wootton found a frequency of 1.04 hz (Xu and Wootton 2004).
Knowing these physiologically relevant values, an experiment was designed.
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4.2 Methodology
4.2.1 Materials
Defibrinated bovine blood (Lampire Biological Laboratories, Inc., Pipersville, PA)
was adjusted to 35% hematocrit using a washing procedure detailed in a previous study
(Carboni, Bognet et al. 2016). Fluorescent polystyrene spheres of 2.11 μm diameter were
suspended in the blood and used as model particles (Spherotech Inc., Lake Forest, IL). This
particle size was chosen because it displayed the most margination in a previous study and,
thus, would be the most affected by subtle changes in the blood flow patterns (Carboni,
Bognet et al. 2016). For microfluidic device fabrication, polydimethylsiloxane (PDMS)
pre-polymer and curing agent were used (Silgard 184 Silicone Elastomer Kit, Krayden Inc.,
Denver, CO).
4.2.2 Device Fabrication
Microfluidic devices were fabricated from a commercially-obtained silicon wafer
master (FlowJEM, Toronto, Canada), as in a previous study. PDMS was used and
established procedures were followed. Briefly, elastomer base and curing agent were mixed
in a 10:1 ratio. The resultant mixture was degassed for 10 minutes to remove air bubbles
and placed in an oven and allowed to cure. The devices were cut out and punched to form
an inlet and an outlet and then plasma bonded (Basic Plasma Cleaner PDC-32G, Harrick
Plasma, Ithaca, NY) to a glass coverslip slide (#1.5, Thermo Fisher Scientific Inc.,
Waltham, MA) using the custom procedure developed in Chapter 2.
4.2.3 Experimental Setup
Blood containing the fluorescent 2.11-µm spherical particles was pumped through
microfluidic devices via the use of a pressure-driven pump system that included a flow
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controller (Fluigent Inc., Villejuif, France). This pump system also included limited
scripting software that was utilized to create a pulsatile flow. While the software was not
capable of directly following a sine wave, scripts were written that set the flow rate to a
value, waited for a length of time and then set the flow rate to 0. The pump was incapable
of instantaneously adjusting the flow rate and required time to fully adjust the flow rate to
the desired value. However, the resultant shape of the flow rate vs time plot over the course
of a given experiment resembled a sine curve naturally, simply by setting the flow rate to
0 or the desired value. Due to the nature of the scripts employed, the pulse flow rate (PFR)
was defined as the flow rate that was set as the maximum, or peak. Similarly, the pulse
wait time (PWT) was defined as the wait time between setting the flow rate to 0 or to the
maximum value. For example, for an experiment employing pulsatile flow ranging
between 0 and 0.6 µL/min, the PFR would be 0.6 µL/min and the PWT might be set to 1
second. In this case, the pump would set the flow rate to 0.6 µL/min from 0, wait 1 second,
set the flow rate to 0, wait 1 second, set the flow rate to 0.6 µL/min, etc.
In order to confirm the fit to a sine wave, the flow rate over time was recorded from
the flow controller. A backbone MATLAB® code for the fitting of sine waves was
obtained from MATLAB® Mathworks® and edited in-house for application to the current
study. It was found that a sine wave was a good fit for the resultant flow rate curves, as
can be seen in Figure 4-1. In this way, a pulsatile flow, similar to that observed
physiologically (Ku, Giddens et al. 1985, Chaturani and Palanisamy 1989, Ojha, Ethier et
al. 1990, Walker, Johnston et al. 2014), was achieved. However, due to the pump requiring
a minimum amount of time to adjust the flow rate to the entered value, the minimum time
between pulses was limited. It was found that PWTs of lower than 1 second could not be
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confidently employed, resulting in curves that were very noisy with very questionable
accuracy and reproducibility (Figure 4-2).

Figure 4-1: Sample sine-wave fit to experimental flow data.
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Figure 4-2: Variation of flow rate while employing a 0.5 second pulse wait time.
Having confirmed the resemblance to a sine wave, fluid was pumped through the
microfluidic device at various PFRs (0.3, 0.6, 1.2 and 2.4 µL/min) and using various PWTs
(1, 1.5, 2, 2.5 and 3 seconds) to explore the effects of variations of the two, both
individually and together. Furthermore, a steady-flow scenario was also investigated. For
each device, a 60,000-frame (~7.5 minutes) time-lapse video was acquired using a dry
objective lens (40x) with a high-speed camera (Andor iXon Ultra 897 iX0897 EMCCD,
130 frames/s, Andor Technology Ltd., Belfast, UK) and an inverted fluorescence
microscope (Nikon Eclipse Ti-E, Nikon Instruments Inc., Melville, NY) with an
Epifluorescence source (Intensilight C-HGFIE, Nikon Instruments Inc., Melville, NY).
After each time-lapse video was collected, the reservoir of blood was gently shaken to keep
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the solution well mixed and the device was perfused at a high flow rate (~8 μL/min) for
approximately 2 minutes. After every 2-3 time lapses, the entire system was flushed for 10
minutes before collection of the next time lapse. These time lapses were all acquired at the
same location and during the same experiment, using the same prepared blood sample.
4.2.4 Analysis
MATLAB® was used to analyze the time-lapse videos. The fluorescent particles
were tracked using code developed in-house. Similar to previous chapters, the tracking
code consists of three steps: first, a background correction was performed to remove any
bright pixels associated with particles adhered to the bottom of the channel. Second, the
position and size of all particles were then calculated using a gradient-based method. The
calculated particle size was used to eliminate out-of-focus particles based on their apparent
larger size. Lastly, the positions of all remaining particles were tracked as a function of
time. However, due to the dependence of velocity on time with pulsatile flow, velocities
were not calculated as they would be extremely variable and wholly dependent upon the
part of the pulsation that the particle was tracked.
4.2.5 Quantifying Margination
In Chapters 2 and 3, the velocity of each particle was calculated and subsequently used
to normalize the particle distributions observed during an experiment. As a result, a
margination parameter with a value of 0.2 indicated a random distribution, displaying no
margination, and values higher than 0.2 were indicative of margination. However, since
the velocity in pulsatile flow is variable and dependent upon when during the pulsation the
particles were tracked, an alternative to the margination parameter is required for
experiments with pulsatile flow. Since the main objectives of this study are internally
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comparative in nature, a simplified, non-normalized margination parameter was defined as
the ratio of the number of particles in the near-wall segments to the total number of particles
as follows:
M non 

p1st segment  p10 th segment

p

(4-1)

i
i th segment 1,10 

Each p in Equation 4-1 is the non-normalized count of particles in a given segment as
opposed to the previous definition where it symbolized the total particle weight for that
segment. Effectively, the non-normalized margination parameter for this chapter is the
percentage of particles that were found to marginate and will be termed Mnon. These values
mean little alone, unlike those in previous chapters, but can still be easily compared to see
the differences in margination between the various experimental conditions in this study.
4.3 Results and Discussion
4.3.1 Steady vs Pulsatile Flow
Figure 4-3 shows Mnon for both a steady flow and pulsatile flow (PFR = 0.6 µL/min,
PWT = 1 second). A significant difference between margination in steady and in pulsatile
flow was not observed. While other studies discovered enhanced degrees of margination
in larger arteries in pulsatile vs steady flow (Phibbs 1966, Goldsmith and Spain 1984, Xu
and Wootton 2004), this phenomenon was not observed in the current experimental
arteriolar system. This could be because of the extremely laminar nature of the flow at a
channel width of 100 µm which may have resulted in a dampening of interactions that led
to the observed enhanced margination in the larger channels or this result could be due to
larger inertial forces that are prevalent with larger Reynolds number flows.
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There was a large degree of error in the pulsatile experiment. To ensure validity of
the results, this experiment and the steady flow experiment were each repeated once and
the initial findings were confirmed – no significant difference between the steady and
pulsatile flow was found in this second repetition either. As a result, the use of a steady or
a pulsatile flow is observed to be largely interchangeable for the flow parameters used in
this Chapter and likely, by extension, for the flow parameters used in Chapter 2 and Chapter
3.

Figure 4-3: Non-normalized margination parameter for steady vs pulsatile flow.
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4.3.2 Effect of Varying Pulse Wait Time
Varying PWT from 1 second to 3 seconds does not have an effect on the
margination parameter. As can be seen in Figure 4-4, despite variations in the wait time
between pulses, Mnon did not vary significantly. Indeed, a one-way ANOVA with a Tukey
comparison test showed that there were no significant differences in the margination
parameter between each of the varying PWT experiments.
To further confirm these results, a variation in PWT from 1 to 2 seconds was carried
out for a PFR of 1.2 µL/min (Figure 4-5). It was hypothesized that in an area of faster flow
where margination would naturally be enhanced (based on the findings in Chapter 2), a
more significant variation may occur between different PWTs. However, these results also
did not show a significant difference when compared to one another. As a result, varying
PWT was found to have no effect on the margination propensity of particles in the current
system. This is likely because inertial effects for the experimental system are negligible
and PWT may have a largely inertial effect on margination, though no studies have
investigated or confirmed this.
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Figure 4-4: Non-normalized margination parameter with a varying pulse wait time. Flow
rate = 0.6 µL/min.
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Figure 4-5: Non-normalized margination parameter with a varying pulse wait time. Flow
rate = 1.2 µL/min.
4.3.3 Effect of Varying Pulse Flow Rate
Figure 4-6 shows the results from varying PFR. A one-way ANOVA was carried out
and all results were found to be significant except for the 0.3 and 0.6 µL/min results, which
were not significant from one another. The trend observed shows higher margination with
a higher PFR which, similar to the findings in Chapter 2, is likely a result of enhanced
particle-RBC interactions with larger flow rates. While this is not a particularly novel
result, the variation of the PFR was effectively a variation of the amplitude of the sine
curves and, thus, the final variable quality of a sine curve.
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Figure 4-6: Non-normalized margination parameter with a varying pulse flow rate. Pulse
wait time = 2 seconds.
4.4 Conclusions
No significant differences were observed between pulsatile and steady flow and
also between varying PWTs. It is possible that the observed increased WBC margination
in other studies between steady and pulsatile flow was dependent on effects that were only
present within the larger channel size (Phibbs 1966, Goldsmith and Spain 1984, Xu and
Wootton 2004). These effects could have been inertial in nature since the channel size and,
therefore, the magnitude of the Reynolds Number is a major difference between those
studies and this one. Unfortunately, this conclusion is difficult to support with the results
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of this study due to the absence of significantly enhanced margination in either case causing
them to be null results. Increasing PFRs were found to lead to increasing margination, as
was expected and following the findings of Chapter 2 for variable shear-rate flow.
Overall, this study did not find major differences between steady and pulsatile flow
for an arteriolar geometry of approximately 100 µm width. The use of steady or pulsatile
flow for this geometry of blood vessel appear to be interchangeable without adverse effects
on experimental data. Furthermore, the results of this study should be applicable to any
geometry wherein the vessel or channel diameter is less than approximately 500 µm, which
is the cutoff for the effects of individual blood cells to become significant (Pries, Secomb
et al. 1996, Lim, Ober et al. 2012, Carugo, Capretto et al. 2013). These results are valuable
for future margination or other experimental studies since steady flow is generally much
more easily employed and replicated as opposed to pulsatile flow which may have
variations depending on the quality of the pumping system, as seen in this study.
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5 Conclusions
5.1 Dissertation Overview
In this dissertation, novel findings related to particle margination were obtained. A
wide variety of particle, flow and geometrical characteristics were investigated and the
effects of each on the margination propensity of particles was quantified and evaluated.
Practically, the findings of this work can be used in the design of drug-carrying particles
in order to maximize drug delivery. Furthermore, a number of these findings can be applied
to in-vitro experiments that seek to further investigate the phenomenon of margination,
simplifying the experiments and providing insight as to the effects that could be observed
from various device designs or experimental apparatuses.
While the main focus of this dissertation was on margination and how each
parameter affects it, a number of other contributions were also made. First, the limitations
of a syringe pump for very low flow rates were realized. Next, a standardized and
normalized definition for margination was developed. Third, the limitations of manualtracking studies and their potential for large error was highlighted.
5.2 Summary of Major Findings and Contributions
Chapter One motivated the research and provided background knowledge
combined with objectives for each portion of this work. Chapter One introduced blood and
detailed the complications of biological fluids. Further, it went on to explain the
phenomenon of margination and how various particle and other properties can affect
particle margination while also highlighting the current experimental understanding of the
phenomenon. A lack of direct tracking studies exists and some adhesion studies are known
to produce results that are questionable thanks to the very nature of adhesion as a
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measurement mechanism. This effectively displays the need for direct tracking studies and
the value of results that look at the entirety of the particle distribution and not just the
marginating particles.
Chapter Two introduced one of the first direct tracking studies of particle
margination and the first automated direct-particle-tracking study. The main original
contributions and scientific findings of Chapter Two are as follows:
1) Discovery of the limitations of a syringe pump; for extremely low flow rates,
the syringe pump creates a chaotic and vaguely pulsatile flow over time as
opposed to the smooth, constant flow rate of a pressure-driven pump
2) Velocity-normalized definition of margination, which allows for an easy
comparison and interpretation of results between experiments and even
potentially between studies
3) Suspending media control experiments highlighted that sedimentation can have
a pronounced effect in this experimental system
4) Large amounts of error were found when analyzing particle counts of 100
whereas particle counts of 1000 had much lower standard deviations; this
highlights a weakness of manual direct tracking studies in that their particle
counts are extremely limited compared to the developed automated direct
tracking methodology
5) The presence of a flow constriction may have non-negligible effects on the
margination of particles and the implicit assumption regarding a uniform
distribution of particles near the inlet of a device cannot be assumed; baseline
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values of margination near the beginning of a device’s length are very important
to measure and consider and may vary with different particle qualities
6) Margination velocity was higher for all particle sizes in blood than in water;
this supports the concept of particle-RBC interactions being a major driving
force for margination, especially since the blood was washed
7) Margination propensity of particles tends to increase with particle size, with a
45% increase upon changing particle size from 0.53 µm diameter to 2.11 µm
diameter
8) Larger particles require more time/device length before they reach their full
margination potential
9) Higher flow rate leads to a higher particle margination
Chapter Three followed from contribution #4 from Chapter Two and worked to
achieve a deeper understanding as to how constriction and expansion regions affect
margination, modelling various geometrical differences in stenosis geometry for not only
in-vitro experimental applications but also for clinical applications in the treatment of
arteriolosclerosis and white-matter stroke. The contributions and findings are as follows:
1) Control results with water and blood as the suspending media showed that the
existence of a region of constriction and/or expansion does have an effect on
particle margination; constrictions appear to have a positive effect and enhance
margination whereas expansions appear to have a negative effect and result in
a reduction in margination
2) Increasing percent occlusion was found to lead to an increasing amount of
particle margination
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3) Increasing constriction length was found to lead to an increasing amount of
particle margination
4) Particle margination decreases as eccentricity increases from 0 to 0.99 and the
constriction becomes more gradual and less sudden; this trend does not hold
when including the N/A eccentricity device, however
5) Particle margination in the case of N/A eccentricity (straight, sudden
constriction/expansion) was found to be most similar to the 0.75 and 0.99
eccentricity devices and much lower than the 0 eccentricity, breaking the
observed trend of particle margination decreasing with an increasing
“gradualness” of a constriction or expansion
Chapter Four investigated the effects of pulsatile flow, dissecting a sine wave
pulsation and comparing the effects on margination of each component as well as the
effects of using a steady flow vs a pulsatile flow experimentally. The contributions and
findings are as follows:
1) No significant difference in the margination of particles between steady,
constant flow and pulsatile flow was observed, implying that the two are
interchangeable for the current experimental system and also possibly for
experimental systems with similar flow patterns, such as for systems with
channel diameters below 500 µm
2) Variation of the wait time between pulses and, thus, the cycle duration did not
result in any significant variations in particle margination
3) Increasing the pulse flow rate and thus the amplitude was observed to lead to
an increase in particle margination
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5.3 Significance and Applications
This work highlights major factors that affect the margination of particles and has a
wide variety of pharmaceutical applications. This research is useful for the general design
of drug-carrying particles in that larger particle sizes were found to marginate the most
effectively over time and, therefore, to deliver their drug payload the most effectively.
However, this assumes that these larger particle sizes are practical for drug delivery which
may not always be the case. However, in some situations it may be possible to utilize an
aggregate of nanoparticles, thus attaining the benefits of enhanced margination as a result
of larger particle size while also retaining the benefit of a small particle for drug delivery
to the targeted site. Relatedly, these results can be applied to the treatment of
arteriolosclerosis since shear-activated nanoparticle clusters have recently become a drug
delivery technique of interest (Holme, Fedotenko et al. 2012, Saxer, Zumbuehl et al. 2013).
Lastly, the discovery that large particles take a longer time to reach their maximum
margination potential shows that, in some cases, smaller particles may actually be desirable
over larger particles, especially when combined with the lower settling velocity of these
smaller particles.
5.4 Future Directions
While a large number of various factors and their effects on margination were
elucidated in this work, there still remains an enormous amount to investigate before
margination is fully understood, especially experimentally. While particle properties such
as size and shape and their effects on margination are now fairly clear, particle density and
stiffness and their effects on margination are not well understood experimentally due to the
inherent difficulty in varying just one of these properties without affecting the other.
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Likewise, little work has been done to study the effects of particle charge on particle-RBC
interactions and, thus, on particle margination except for one study involving charged
liposomes (D’Apolito, Bochicchio et al. 2017). For now, it is important to simply continue
investigating the variations of one property to achieve a better understanding of how that
property can affect margination. Especially in the case of properties such as particle shape,
where the orientation of a particle can cause enormous variations in the adhesion strength,
direct-tracking studies of these particle properties under a standardized experimental
protocol is desirable for a full and general understanding of each property. Once each
property is well understood between studies, each of which employs similar experimental
systems and practices, an ideal later or capstone study would vary each of these properties
with the others and find the overall ideal particle for drug delivery. Taking into account
and varying particle size, shape, stiffness, density and charge within a single study would
be challenging but could lead to a “master” particle design for maximum margination. The
physiological and realistic limitations on drug-carrier properties and the drug delivery
mechanism should also be considered as well as the channel size/hematocrit, allowing for
the design of a particle that not only marginates extremely well but also delivers its payload
effectively despite the blood vessel size and local hematocrit variations that are naturally
present in the body.
The effects of hematocrit variations on margination are still not well-understood
either. Although it can be hypothesized based on current simulation work that an increasing
hematocrit leads to enhanced particle-RBC interactions and, in turn, higher particle
margination, this extrapolation does not take into account effects like the potential
disappearance of the CFL with higher hematocrits and the effects that this could have on
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particle margination. The absence of a CFL would mean that particles would not cease
interacting with RBCs once they have marginated and could actually lead to a decrease in
margination if the RBCs then push these particles back towards the centerline with them.
The extrapolation of the effects of parameters such as the hematocrit on margination may
not always be accurate due to variations near the extremes or even in middle-ranges. The
amount of interactions and flow properties that are changed by varying a parameter like
hematocrit means that the effects on particle behavior is not as predictable as modeling
studies may indicate and these studies are limited in the amount of RBCs and, thus, the
channel size that can be simulated as well. Lastly, hematocrit can also vary with channel
or blood vessel size and this introduces an entire new level of complexity when exploring
its effects. As such, further experimental work exploring the effects of varying hematocrit,
especially involving different channel sizes, is necessary in order to fully understand it.
The study of margination is undoubtedly important but it is also important to
consider the delivery of the drug to the targeted site as well, after margination has occurred.
During the course of this work, preliminary experiments with a flow chamber (RC-50
Imaging Chamber, Warner Instruments, LLC, Hamden, CT) were performed. This flow
chamber is comprised of two separate channels and a membrane that is sandwiched
between them and is shown in Figure 5-1. The ultimate goal of this work was to mimic a
blood vessel and tumor system using a thin membrane, with a designated pore size, inside
of the flow chamber which could eventually be replaced with a cultured membrane of
endothelial or perhaps even cancer-affected endothelial cells, which would have enhanced
spacing.
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Figure 5-1: (a) Diagram of the exploded flow chamber, with each individual component
labeled and (b) the assembled flow chamber with some inlet/outlet tubing attached.

Figure 5-2: Diagram of eventual experimental setup.
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As shown in Figure 5-2, the bottom chamber would be held static, without flow.
Sandwiched between this channel and the upper channel would be a porous membrane,
which would serve to mimic the area near a targeted site for drug delivery. Initially, this
was planned to have a pore size of ~2 µm, representing the largest endothelial cell spacing
that has been observed near a tumor site. However, this membrane would ideally consist
of live cells for a more realistic system. Finally, the top channel would be perfused with
blood, containing fluorescent particles that will serve to represent drug-carrying particles.
Some preliminary results were obtained with this membrane, as shown in Figure 5-3, where
0.53 µm diameter particles were observed to successfully move through the pores and to
the other side of the membrane from the flow-side.

Figure 5-3: Example images showing the appearance of two 0.53 µm diameter particles
after they traveled through an opaque, porous membrane with a pore diameter of 2 µm.
Margination and drug delivery could be simultaneously quantified by examination
of the particle concentration in the bottom, static chamber at the end of an experiment with
this setup. Overall, this would be a rigorous experiment involving not only margination but
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also the actual drug delivery itself, something which margination studies tend to gloss over
in favor of an in-depth look at only the margination of a particle. On the other hand, many
studies have, for example, examined the transport of drug-carrying particles into a tumor
but have not examined the margination involved (Kyle, Huxham et al. 2004, Dreher, Liu
et al. 2006, Prabhakarpandian, Pant et al. 2008, Hsiao, Torisawa et al. 2009, Rosano, Tousi
et al. 2009, Fukumura, Duda et al. 2010, Prabhakarpandian, Shen et al. 2011,
Zervantonakis, Kothapalli et al. 2011, LaBarbera, Reid et al. 2012, Zervantonakis, HughesAlford et al. 2012, Breslin and O'Driscoll 2013, Moya, Tran et al. 2013, Verbridge,
Chakrabarti et al. 2013, Vidi, Maleki et al. 2014, Prabhakarpandian, Shen et al. 2015). The
combination of margination and drug delivery into one study could provide valuable
knowledge regarding the interplay between the two. Further, the membrane could be varied
easily in order to mimic different disease sites or tumor sites and how different receptors
or other factors could impact drug delivery when combined with particle margination.
Other future directions of this research may also involve an investigation of how
margination is related to channel size. No studies currently explore the effects of blood
vessel size on margination beyond stating that the cutoff blood vessel diameter for the
formation of a CFL is approximately 300 or 500 µm (Pries, Secomb et al. 1996, Lim, Ober
et al. 2012, Carugo, Capretto et al. 2013). The effect of channel size on margination is not
only relevant for in-vitro studies but also has physiological relevance as particles must
navigate through a wide variety of differently-sized blood vessels. In particular, almost all
current experimental in-vitro margination studies use an arbitrary channel size that is rarely
the same as that used in another study. As such, comparison of results between studies can
be difficult if channel size varies a lot, since hematocrit also varies with channel size.
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Indeed, as mentioned before, a study on the variations of hematocrit and channel size and
their effects on margination would be extremely useful to bridge the gap, so to speak,
between all current experimental margination literature where differing hematocrits and
channel sizes were selected. There exists the implicit assumption in current experimental
margination literature that the results of one in-vitro study are comparable to those of
another, even if both studies used only similar channel size, hematocrit and other
experimental parameters instead of values that were exactly the same. This assumption,
while not unreasonable, is not supported by any current study of margination and so a study
that confirms or denies the validity of such study-to-study comparisons that operate with
different channel sizes or slightly different hematocrits etc. would be valuable.
Lastly, the current experimental studies of margination that employ microfluidics
involve a channel with a square or rectangular cross-section. The applicability of this as a
representation of a blood vessel is questionable given that blood vessel cross-sections are
well-known to be circular. While it was not extremely important for the current work by
nature of imaging margination only on one place of the device, an investigation into the
effects of different cross-sectional geometries on margination could prove interesting if the
square or rectangular cross-section is found to alter the flow behavior or RBC-RBC or
RBC-particle interactions in some unexpected way. Indeed, a study of WBC margination
in a bifurcating microfluidic device found that switching from a rectangular cross-section
to a circular cross-section resulted in a complete reversal of the distribution of marginated
leukocytes among the branches of a bifurcation (Yang, Forouzan et al. 2011).
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Figure 5-4: Images of device channels after attempting to use uncured PDMS to make a
circular (or ovular) cross-section device (a) Just after the inlet landing pad, which can be
seen to the right, some bumpiness on the lower wall (b) Slightly up-channel, another bump
at the lower wall (c) Majorly misshapen part of the channel (d) Outlet of the device, the
uncured PDMS was unable to be completely expelled and ended up sealing the outlet so
that flow could not be perfused through the device.
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There exist techniques for forming a circular cross-section in a microfluidic device
from a square cross-section (Yang, Forouzan et al. 2011) and a preliminary attempt during
the course of this work yielded partial success. Briefly, uncured PDMS is injected into a
fully-cured and plasma bonded device. Next, air is injected so as to push out the uncured
PDMS. The device is then placed onto a hot plate to cure and the resultant geometry is
approximately circular. However, multiple issues with this procedure were encountered
during an initial attempt. First, some of this PDMS clings to the walls and was not
completely removed, resulting in a number of irregularities in the channel, with random
variations in width throughout it without a discernible pattern. These variations can be seen
in Figure 5-4, with Figure 5-4(c) showing a particularly large misshapen device portion.
Figure 5(d) also showcases another major problem – not all of the PDMS was able to be
pushed out of the device, likely due to the landing pad outlet region. The residual PDMS
cured and sealed the outlet, preventing flow from perfusing throughout the device and
leaving the device. With a more controlled and precise air flow while pushing out the
PDMS, a circular cross-section device may be achievable. A study such as this would be
feasible but the ability to precisely control the shape and smoothness of the final product
for reproducibility purposes and consistency between experiments would be a major
challenge. Furthermore, the outlet issue may not be solved by simply removing the landing
pad region, which would also be a major challenge if the outlet were to keep sealing itself
as a result of the injected PDMS. It is possible that faster airflow may solve this issue, but
the residual PDMS is the issue and may relax and end up sealing the outlet anyway. This
study would be dependent upon the solution of these two major issues.
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